Resistenzen bei tierpathogenen Bakterien – ein Update · Symposium Antibiotikaresistenz in der LM...

39
Resistenzen bei tierpathogenen Bakterien – ein Update

Transcript of Resistenzen bei tierpathogenen Bakterien – ein Update · Symposium Antibiotikaresistenz in der LM...

  • Resistenzen bei tierpathogenen Bakterien – ein Update

  • Seite 2

    Die Welt der übertragbaren Resistenzen

    Symposium Antibiotikaresistenz in der LM-Kette, Heike Kaspar

  • Seite 3

    Makrolide Penicilline

    Polypeptide Fluorchinolone Cephalosporine Aminoglykoside

    Diaminopyrimidine Pleuromutiline Lincosamide Sulfonamide Tetrazykline

    Fenicole

    Carbapeneme Glycopeptide Glycylcycline Monobactame Streptogramine Quinoxaline Ansamycine Zyklische- Lipopeptide Oxazolidinone Ketolide

    Veterinärmedizin Humanmedizin

    Zugelassene Wirkstoffklassen

    Symposium Antibiotikaresistenz in der LM-Kette, Heike Kaspar

  • Seite 4 Symposium Antibiotikaresistenz in der LM-Kette, Heike Kaspar

    Nationales Resistenzmonitoring bei tierpathogenen Erregern in Deutschland Zielstellung Datenbasis für die Abschätzung von Risiken und Ableitung von Managementmaßnahmen Einschätzung des Risikos, das aus dem Tierbereich auf den Menschen einwirken kann Früherkennung von Resistenz (u. a. „empirische“ Therapie) Trends der Resistenzentwicklung erfassen Epidemiologische Zusammenhänge aufklären

  • Seite 5 Symposium Antibiotikaresistenz in der LM-Kette, Heike Kaspar

    Nationales Resistenzmonitoring bei tierpathogenen Erregern in Deutschland Hintergrund • Resistenzen haben einen „One Health“ Bezug, dies gilt für den

    Menschen, das Tier und die Umwelt • Resistenzmonitoring auf Basis §77 Abs. 3, AMG regelmäßige Berichtspflicht des BVL zu Resistenzdaten von klinischen

    Isolaten • BVL entwickelt jährlich einen dezidierten Stichprobenplan unter Berücksichtigung von aktuellen Entwicklungen • Isolateinsendung von Laboren an BVL zur Resistenzbestimmung

  • Seite 6 Symposium Antibiotikaresistenz in der LM-Kette, Heike Kaspar

    Konzeption Resistenzmonitoring

    Antibiotikaresistenzmonitoring GERM Vet

    nationales Resistenzmonitoring veterinärpathogener Bakterien seit 2001

    ca. 3500 – 4000 Isolate pro Jahr

    klinisch erkrankte Tiere

    Lebensmittel liefernde Tiere

    nicht-Lebensmittel liefernde Tiere (Hobbytiere)

    unauffällige Tiere

    Lebensmittel tierischer Herkunft

  • Seite 7

    Stichprobenplan (LM liefernde Tiere)

    Tierart Indikation Organ Bakterienspzies

    Milchrind Mastitis Milch, Euter

    Klebsiella spp. Streptococcus spp. Enterococcus spp. E. coli

    Kalb, Rind Erkrankungen des Respirationstraktes Bronchien, Lunge Mannheimia spp. Pasteurella multocida

    Schwein Enteritis Darm, Kot E. coli

    Schwein Hautinfektionen Haut S. aureus S. hyicus

    Sammelzeitraum 25.4.2018 – 31.03.2019

    Symposium Antibiotikaresistenz in der LM-Kette, Heike Kaspar

  • Seite 8 Symposium Antibiotikaresistenz in der LM-Kette, Heike Kaspar Seite 8

    Quantitative Methode: Bouillon-Mikrodilution

    Ampicillin Cephalothin CHL Enrofloxacin Penicillin G Tetracyclin Vancomycin SXT

    Wirkstoff [mg/L] MHK

    + +

    Bewertung der Ergebnisse

    • klinische Grenzwerte gemäß CLSI (VET01 5th. ed, VET08)

    • veterinärspezifische GW Adaption humanspezifischer GW

    • wenn keine GW verfügbar: Beurteilung des MHK90- Wertes

    • Angaben zu Resistenzraten nur bei vorhandenen Grenzwerten

  • Seite 9 Symposium Antibiotikaresistenz in der LM-Kette, Heike Kaspar

    Bewertungskriterien

    Begriffsbestimmung – Nomenklatur Klinische Grenzwerte Sensibel

    Intermediär bezogen auf die Wahrscheinlichkeit des

    Resistent Therapie erfolges

    Epidemiologische Cut-off-Werte

    Wildtyp im Bereich der Normalverteilung

    Nicht-Wildtyp außerhalb der Normalverteilung

    Hinweis auf erworbene Resistenz

  • Seite 10 Symposium Antibiotikaresistenz in der LM-Kette, Heike Kaspar Seite 10

    Grenzwert

    0

    10

    20

    30

    40

    50

    60

    0,06 0,12 0,25 0,5 1 2 4 8 16 32 64Tetracyclin, MHK [mg/L]

    M. haemolytica (n = 131), Rind

    Klinischer breakpoint ≥ 16 (CLSI)

    Epidemiolog. Cut-off ≥ 4

    Auswertung der Ergebnisse

  • Seite 11 Symposium Antibiotikaresistenz in der LM-Kette, Heike Kaspar Seite 11

    Ergebnisse des Nationalen Resistenzmonitoring

    Respiratorische Erkrankungen

  • Seite 12 Symposium Antibiotikaresistenz in der LM-Kette, Heike Kaspar Seite 12

    APP, Schwein, Indikation: respiratorische Erkrankungen 2008 - 2014

    AMP Ampicillin, CEF Cephalothin, XNL Ceftiofur, ENR Enrofloxacin, FFN Florfenicol, TET Tetracyclin, TIA Tiamulin, TIL Tilmicosin

    Ergebnisse

  • Seite 13 Symposium Antibiotikaresistenz in der LM-Kette, Heike Kaspar Seite 13

    APP, Schwein, Indikation: respiratorische Erkrankungen MHK90-Daten 2008 - 2014

    Ergebnisse

    MHK90 [mg/L]

    Studienjahr

    Wirkstoffe, für die keine klinischen Grenzwerte vorhanden sind

    2008 2009 2010 2011 2012 2013 2014

    Cefotaxim 0,015 0,015 0,015 0,25 0,015 0,015 0,015 Cefquinom 0,03 0,03 0,03 0,5 0,03 0,03 0,03 Doxycyclin 1 2 2 8 2 2 1 Gentamicin 16 16 8 8 16 16 16 Nalidixinsäure 4 4 4 4 4 4 4 SXT 0,12 0,25 0,12 0,12 0,12 0,12 0,25 Tulathromycin 32 32 16 16 - 32 32 N = 63 40 58 46 41 102 101

  • Seite 14 Symposium Antibiotikaresistenz in der LM-Kette, Heike Kaspar Seite 14

    P. multocida, Rind, Indikation: respiratorische Erkrankungen; 2008 - 2017

    Ergebnisse

    Diagramm1

    CeftiofurCeftiofurCeftiofurCeftiofurCeftiofurCeftiofurCeftiofurCeftiofurCeftiofur

    EnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacin

    FlorfenicolFlorfenicolFlorfenicolFlorfenicolFlorfenicolFlorfenicolFlorfenicolFlorfenicolFlorfenicol

    PenicillinPenicillinPenicillinPenicillinPenicillinPenicillinPenicillinPenicillinPenicillin

    TulathromycinTulathromycinTulathromycinTulathromycinTulathromycinTulathromycinTulathromycinTulathromycinTulathromycin

    TetracyclinTetracyclinTetracyclinTetracyclinTetracyclinTetracyclinTetracyclinTetracyclinTetracyclin

    2008 N=75

    2009 N=68

    2010 N=25

    2011 N=72

    2012 N=77

    2013 N=48

    2014 N=75

    2016 N=99

    2017 N=64

    resistente Stämme [%]

    1

    0

    0

    0

    0

    0

    0

    0

    0

    1

    0

    4

    0

    0

    0

    1.3

    0

    1.6

    1

    0

    0

    1.4

    1.3

    0

    0

    3

    1.6

    1.3

    3.2

    0

    5.6

    1.3

    2.1

    0

    2

    3.1

    0

    0

    0

    0

    0

    0

    3

    12.7

    7

    13

    4

    12.5

    5.2

    10.4

    6.7

    15

    30.2

    Rind

    PasteurellaRindalle Produktionsstufen

    2008 N=752009 N=682010 N=252011 N=722012 N=772013 N=482014 N=752016 N=992017 N=64

    Ceftiofur100000000

    Enrofloxacin1040001.301.6

    Florfenicol1001.41.30031.6

    Penicillin1.33.205.61.32.1023.1

    Tulathromycin000000312.7

    Tetracyclin713412.55.210.46.71530.2

    n=756825727748759964603

    Wirkstoffe, für die keine klinischen Grenzwerte vorhanden sindMHK90 [mg/L]

    Studienjahr200820092010201120122013201420162017

    Ampicillin0.250.50.510.250.250.50.250.5

    Cefoperazon0.060.0610.060.0150.060.060.060.06

    Cefotaxim0.0150.0150.030.0150.0150.0150.0150.0150.015

    Cefquinom0.060.060.060.060.0150.060.060.060.06

    Colistin444424284

    Doxycyclin12110.51111

    Marbofloxacinn.g.n.g.n.g.n.g.0.060.120.060.060.06

    Nalidixinsäure42244128222

    Neomycinn.g.n.g.n.g.n.g.n.g.163216>64

    Streptomycinn.g.n.g.n.g.n.g.n.g.>51264>512>512

    Tilmicosin888881688128

    Trimethoprim/Sulfamethoxazol0.50.250.250.250.252160.251

    Anzahl Isolate (N)756821727748759964

    2008 N=752009 N=682010 N=212011 N=722012 N=772013 N=482014 N=752016 N=992017 N=64

    Ampicillin0.250.50.510.250.250.50.250.5

    Cefotaxim0.0150.0150.030.0150.0150.0150.0150.0150.015

    Doxycyclin12110.51111

    Marbofloxacinn.g.n.g.n.g.n.g.0.060.120.060.060.06

    Nalidixinsäure42244128222

    Tilmicosin888881688128

    Trim/Sulf0.50.250.250.250.252160.251

    756821727748759964

    Rind

    2008 N=75

    2009 N=68

    2010 N=25

    2011 N=72

    2012 N=77

    2013 N=48

    2014 N=75

    2016 N=99

    2017 N=64

    resistente Stämme [%]

    Katze

    2008 N=75

    2009 N=68

    2010 N=21

    2011 N=72

    2012 N=77

    2013 N=48

    2014 N=75

    2016 N=99

    2017 N=64

    log2 MHK90-Wert

    Wirkstoffe, für die keine klinischen Grenzwerte vorhanden sindMHK90 [mg/L]

    Studienjahr2010201120122013/201420152016

    Ampicillin0.50.510.250.250.25

    Amoxicillin/Clavulansäure0.50.50.50.50.50.5

    Cefoperazon0.060.060.120.060.060.06

    Cefotaxim0.0150.0150.030.0150.0150.015

    Cefquinom0.060.060.120.060.0150.06

    Ceftiofur0.030.0150.060.060.030.06

    Doxycyclin0.50.50.250.250.250.25

    Enrofloxacin0.030.030.030.030.030.03

    Gentamicin444444

    Marbofloxacinn.g.n.g.0.030.060.030.03

    Nalidixinsäure224122

    Penicillin0.250.250.250.250.250.25

    Tetracyclin10.510.50.50.5

    Trimethoprim/Sulfamethoxazol0.120.120.12320.060.12

    Anzahl Isolate (N)6410918232019

  • Seite 15 Symposium Antibiotikaresistenz in der LM-Kette, Heike Kaspar

    0

    5

    10

    15

    20

    25re

    sist

    ente

    Stä

    mm

    e [ %

    ]

    2008 N=217 2009 N=154 2010 N=73 2013 N=151 2015 N=145

    P. multocida, Schwein, Indikation: respiratorische Erkrankungen; 2008 - 2015

    Diagramm1

    AmpicillinAmpicillinAmpicillinAmpicillinAmpicillin

    CeftiofurCeftiofurCeftiofurCeftiofurCeftiofur

    EnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacin

    FlorfenicolFlorfenicolFlorfenicolFlorfenicolFlorfenicol

    PenicillinPenicillinPenicillinPenicillinPenicillin

    TetracyclinTetracyclinTetracyclinTetracyclinTetracyclin

    TilmicosinTilmicosinTilmicosinTilmicosinTilmicosin

    TulathromycinTulathromycinTulathromycinTulathromycinTulathromycin

    2008 N=217

    2009 N=154

    2010 N=73

    2013 N=151

    2015 N=145

    resistente Stämme [ %]

    6.5

    5.8

    4.1

    4

    1.4

    0

    0

    2.7

    0

    0

    0.9

    0

    0

    0.7

    0.7

    0

    0.6

    1.4

    0.7

    0

    6.9

    5.8

    8.2

    4

    1.4

    21.7

    18.2

    17.8

    8.7

    8.3

    0.9

    0

    4.1

    0

    0.7

    0.5

    0

    2.7

    0

    0.7

    Pasteurella Schwein

    2008 N=2172009 N=1542010 N=732013 N=1512015 N=145Pasteurella Schwein

    Ampicillin6.55.84.141.4

    Ceftiofur002.700

    Enrofloxacin0.9000.70.7

    Florfenicol00.61.40.70

    Penicillin6.95.88.241.4

    Tetracyclin21.718.217.88.78.3

    Tilmicosin0.904.100.7

    Tulathromycin0.502.700.7

    n21715473151145

    Pasteurella Schwein

    2008 N=217

    2009 N=154

    2010 N=73

    2013 N=151

    2015 N=145

    resistente Stämme [ %]

    Tabelle1

  • Seite 16 Symposium Antibiotikaresistenz in der LM-Kette, Heike Kaspar Seite 16

    Ergebnisse des Nationalen Resistenzmonitoring

    Enteritis

  • Seite 17 Symposium Antibiotikaresistenz in der LM-Kette, Heike Kaspar Seite 17

    E. coli, Ferkel, Indikation: Enteritis; 2006 - 2017

    Ergebnisse

    0

    10

    20

    30

    40

    50

    60

    70

    80

    90

    100

    Ampicillin Amox/Clav Chloramphenicol Gentamicin Tetrazyklin Trimeth/Sulfa

    [%] r

    esis

    tent

    e St

    ämm

    e

    2006/2007 N=345 2008 N=240 2009 N=124 2010 N=156 2011 N=183

    2012 N=150 2015 N=134 2016 N=133 2017 N=118

    Chloramphenicol nur bis 2012 untersucht

    Diagramm1

    AmpicillinAmpicillinAmpicillinAmpicillinAmpicillinAmpicillinAmpicillinAmpicillinAmpicillin

    Amox/ClavAmox/ClavAmox/ClavAmox/ClavAmox/ClavAmox/ClavAmox/ClavAmox/ClavAmox/Clav

    ChloramphenicolChloramphenicolChloramphenicolChloramphenicolChloramphenicolChloramphenicolChloramphenicolChloramphenicolChloramphenicol

    GentamicinGentamicinGentamicinGentamicinGentamicinGentamicinGentamicinGentamicinGentamicin

    TetrazyklinTetrazyklinTetrazyklinTetrazyklinTetrazyklinTetrazyklinTetrazyklinTetrazyklinTetrazyklin

    Trimeth/SulfaTrimeth/SulfaTrimeth/SulfaTrimeth/SulfaTrimeth/SulfaTrimeth/SulfaTrimeth/SulfaTrimeth/SulfaTrimeth/Sulfa

    2006/2007 N=345

    2008 N=240

    2009 N=124

    2010 N=156

    2011 N=183

    2012 N=150

    2015 N=134

    2016 N=133

    2017 N=118

    [%] resistente Stämme

    62

    67

    69

    71.4

    75.4

    74

    57.5

    62.4

    62.7

    3

    2

    2

    11.3

    2.2

    1.3

    3

    0

    3.4

    31

    26

    27

    24.2

    32.8

    22.7

    10

    6

    11

    13

    10.9

    11.3

    2.2

    6.8

    7.7

    80

    73

    77

    78.9

    79.2

    72.7

    59.7

    62.4

    55.6

    50

    50

    61

    55.9

    59

    56

    43.3

    51.1

    45.3

    Kalb

    E. coli Kalb

    2006/2007 N=1542008 N=1662009 N=1602010 N=1432011 N=1612012 N=2872013 N=2502014 N=2842015 N=1692016 N=1142017 N=114

    Ampicillin687076.376.979.776.377.671.568.666.775.4

    Amox/Clav18161519.617.41518.821.52610.516.7

    Cephalothin443741.348.342.446.439.4424349.1

    Chloramph495150.659.455.548.1

    Gentamicin2321253539.928.640.437.722.519.324.6

    Tetrazyklin717168.169.275.770.474.463.759.86465.8

    Trimeth/Sulfa445148.152.449.457.855.647.242.639.544.7

    Summe

    n=1541661601431732872502841691141142014

    2006/2007 N=1542008 N=1662009 N=1602010 N=1432011 N=1612012 N=2872013 N=2502014 N=2842015 N=1692016 N=1142017 N=114

    Imipenemn.g.n.g.n.g.n.g.n.g.0.250.250.250.250.250.25

    Colistin0.50.50.5121120.50.50.5

    Nalidixinsäure256256256256256256256256256256256

    Ciprofloxacinn.g.n.g.n.g.n.g.n.g.323232323232

    Enrofloxacin3232323232323232323232

    Cefotaxim116326464646464646464

    Ceftiofur264128128128128128128128128128

    Kalb

    2006/2007 N=154

    2008 N=166

    2009 N=160

    2010 N=143

    2011 N=161

    2012 N=287

    2013 N=250

    resistente Stämme [%]Achsentitel

    ESBL

    2006/2007 N=154

    2008 N=166

    2009 N=160

    2010 N=143

    2011 N=161

    2012 N=287

    2013 N=250

    2014 N=284

    2015 N=169

    2016 N=114

    2017 N=114

    [%] resistente Stämme

    Tabelle2

    2006/2007 N=154

    2008 N=166

    2009 N=160

    2010 N=143

    2011 N=161

    2012 N=287

    2013 N=250

    2014 N=284

    2015 N=169

    2016 N=114

    2017 N=114

    log2 MHK90-Wert

    Ferkel

    ESBL Kalb

    JahrKalbSchweinGeflügel

    2006/200772.30.2

    20081141.4

    2009193.81.8

    2010183.91.4

    201125.410.63.6

    2012207.92.3

    201329.20.6

    2014340.6

    201526.75.51

    201629.83.73.6

    Ferkel

    2006/2007

    2008

    2009

    2010

    2011

    2012

    2013

    2014

    2015

    2016

    Prävalenz ESBL bildender E. coli [%]

    Pute

    Masthahn

    E. coliFerkel

    2006/2007 N=3452008 N=2402009 N=1242010 N=1562011 N=1832012 N=1502015 N=1342016 N=1332017 N=118

    Ampicillin62676971.475.47457.562.462.7

    Amox/Clav32211.32.21.3303.4

    Chloramphenicol31262724.232.822.7

    Gentamicin106111310.911.32.26.87.7

    Tetrazyklin80737778.979.272.759.762.455.6

    Trimeth/Sulfa50506155.9595643.351.145.3

    Summe

    n=3452401241561831501341331181583

    2006/2007 N=3452008 N=2402009 N=1242010 N=1562011 N=1832012 N=1502015 N=1342016 N=1332017 N=118

    Imipenemn.g.n.g.n.g.n.g.n.g.0.250.250.250.25

    Colistin40.5488880.54

    Nalidixinsäure128256256128128256256128128

    Ciprofloxacinn.g.n.g.n.g.n.g.n.g.40.50.50.5

    Enrofloxacin0.5110.50.58211

    Cefotaxim0.120.120.120.120.120.50.120.120.12

    Ceftiofur0.50.50.50.50.5110.50.5

    Masthahn

    2006/2007 N=345

    2008 N=240

    2009 N=124

    2010 N=156

    2011 N=183

    2012 N=150

    2015 N=134

    2016 N=133

    2017 N=118

    [%] resistente Stämme

    Colistin

    2006/2007 N=345

    2008 N=240

    2009 N=124

    2010 N=156

    2011 N=183

    2012 N=150

    2015 N=134

    2016 N=133

    2017 N=118

    log2 MHK90-Wert

    E. coli PutePutealle Indikationen

    2006/2007 N=1662006/2007 N=1662008 N=1332009 N=852010 N=952011 N=1252012 N=1592013 N=1092014 N=1102015 N=1142016 N=962017 N=64

    Ampicillin61.961.965.473.542.159.749.7334033.343.845.3

    Amoxi/Clav2.42.41.55.31.151.30.91.82.63.10

    Cephalothin42.842.836.833.422.1208.314.513.215.626.6

    Chloramph14.914.921.126.621.125.818.922

    Enrofloxacin334.504.21.51.35.56.46.15.26.3

    Gentamicin1.81.82.32.311.613.68.803.72.66.39.4

    Tetrazyklin70.270.262.452.836.84827.716.537.315.82523.4

    Trimet/Sulfa35.735.721.821.521.122.425.88.330713.510.9

    n=166166133859512515910911011496641422

    2006/2007 N=1662008 N=1332009 N=852010 N=952011 N=1252012 N=1592013 N=1092014 N=1102015 N=1142016 N=962017 N=64

    Imipenemn.g.n.g.n.g.n.g.0.250.250.250.250.250.250.25

    Colistin0.50.580.588120.50.50.5

    Nalidixinsäure256128128256256256128256128256128

    Ciprofloxacinn.g.n.g.n.g.n.g.0.250.50.50.50.50.50.5

    Cefotaxim0.120.120.120.120.120.120.120.120.120.120.12

    Ceftiofur0.50.50.50.50.50.50.50.50.50.50.5

    2006/2007 N=166

    2006/2007 N=166

    2008 N=133

    2009 N=85

    2010 N=95

    2011 N=125

    2012 N=159

    2013 N=109

    2014 N=110

    2015 N=114

    2016 N=96

    2017 N=64

    [%] resistente Stämme

    2006/2007 N=166

    2008 N=133

    2009 N=85

    2010 N=95

    2011 N=125

    2012 N=159

    2013 N=109

    2014 N=110

    2015 N=114

    2016 N=96

    2017 N=64

    log2 MHK90-Wert

    E. coliMasthahn

    2006/2007 N=302008 N=212009 N=292010 N=422011 N=742012 N=352013 N=382014 N=312015 N=1092016 N=772017 N=45

    Ampicillin6343525035.642.935.838.73335.144.4

    Amoxi/Clav1710311.91.411.4001.86.52.2

    Cephalothin37242723.825.915.86.56.415.615.6

    Chloramph10537.16.88.617.6

    Enrofloxacin3539.59.65.75.39.76.42.62.2

    Gentamicin3004.89.614.37.93.23.77.82.2

    Tetrazyklin40242133.335.634.323.735.516.518.226.7

    Trimet/Sulfa4314301916.414.318.425.823.916.920

    n=30212942743538311097745531

    2006/2007 N=302008 N=212009 N=292010 N=422011 N=742012 N=352013 N=382014 N=312015 N=1092016 N=772017 N=45

    Ceftiofur10.50.540.5160.50.50.50.50.5

    Cefotaxim0.50.120.1240.12160.120.120.120.250.12

    Nalidixinsäure256256256256256256256256256128256

    Ciprofloxacinn.g.n.g.n.g.n.g.n.g.0.50.540.50.50.5

    Colistin0.50.50.5111110.50.50.5

    0.0150.030.060.120.250.51248163264

    log2

    -6-5-4-3-2-10123456

    2006/2007 N=302008 N=212009 N=292010 N=422011 N=742012 N=352013 N=382014 N=312015 N=109

    Ceftiofur0-1-12-14-1-1-1

    Cefotaxim-1-3-32-34-3-3-3

    Nalidixinsäure888888888

    Ciprofloxacinn.g.n.g.n.g.n.g.n.g.-1-12-1

    Colistin-1-1-100000-1

    2006/2007 N=30

    2008 N=21

    2009 N=29

    2010 N=42

    2011 N=74

    2012 N=35

    2013 N=38

    2014 N=31

    2015 N=109

    2016 N=77

    2017 N=45

    [%] resistente Stämme

    2006/2007 N=30

    2008 N=21

    2009 N=29

    2010 N=42

    2011 N=74

    2012 N=35

    2013 N=38

    2014 N=31

    2015 N=109

    2016 N=77

    2017 N=45

    log2 MHK90-Wert

    Tab. 1.6. Anteil mcr-1 positiver Isolate an Colistin-resistenten (E. coli)

    SchweinRindGeflügelOthers

    2004/050%0%0%0%

    2005/060%0%0%0%

    2006/076%25%33%0%

    20085%0%64%0%

    200927%0%92%0%

    201047%45%77%0%

    201149%0%85%0%

    201244%0%95%100%

    2013*62%25%0%

    2014*45%57%0%

    201554%0%50%0%

    Table 1.4. Anteil Colistin-resistenter Isolate am Probeneingang

    SchweinRindGeflügelOthers

    2004/055.1%0.7%0.5%0.0%

    2005/063.5%1.1%0.4%0.0%

    2006/079.7%2.2%2.7%3.6%

    20085.7%4.5%3.3%4.5%

    20099.4%3.4%5.5%0.0%

    201012.4%2.2%4.5%0.8%

    201117.8%1.5%5.3%1.7%

    201215.8%0.7%5.2%0.0%

    2013*4.9%1.1%0.0%

    2014*2.1%2.1%1.1%

    201512.3%3.4%0.5%1.0%

    Table 1.5. Anteil mcr-1 positiver Isolate am Probeneingang (E. coli)

    SchweinRindGeflügelOthers

    2004/050.0%0.0%0.0%0.0%

    2005/060.0%0.0%0.0%0.0%

    2006/070.6%0.5%0.9%0.0%

    20080.3%0.0%2.1%0.0%

    20092.6%0.0%5.1%0.0%

    20105.8%1.0%3.4%0.0%

    20118.7%0.0%4.5%0.0%

    20126.9%0.0%5.0%1.7%

    2013*3.0%0.3%0.0%

    2014*0.9%1.2%0.0%

    20156.6%0.0%0.3%0.0%

    Schwein

    Rind

    Geflügel

    Schwein

    Rind

    Geflügel

    Schwein

    Rind

    Geflügel

  • Seite 18 Symposium Antibiotikaresistenz in der LM-Kette, Heike Kaspar Seite 18

    E. coli, MHK90-Daten, Ferkel, Indikation: Enteritis; 2006 - 2017

    Ergebnisse

    Ciprofloxacin ab 2012 untersucht

    Diagramm1

    ColistinColistinColistinColistinColistinColistinColistinColistin

    NalidixinsäureNalidixinsäureNalidixinsäureNalidixinsäureNalidixinsäureNalidixinsäureNalidixinsäureNalidixinsäure

    CiprofloxacinCiprofloxacinCiprofloxacinCiprofloxacinCiprofloxacinCiprofloxacinCiprofloxacinCiprofloxacin

    EnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacin

    CefotaximCefotaximCefotaximCefotaximCefotaximCefotaximCefotaximCefotaxim

    CeftiofurCeftiofurCeftiofurCeftiofurCeftiofurCeftiofurCeftiofurCeftiofur

    2006/2007 N=345

    2008 N=240

    2009 N=124

    2010 N=156

    2011 N=183

    2012 N=150

    2015 N=134

    2016 N=133

    log2 MHK90-Wert

    4

    0.5

    4

    8

    8

    8

    8

    0.5

    128

    256

    256

    128

    128

    256

    256

    128

    0

    0

    0

    0

    0

    4

    0.5

    0.5

    0.5

    1

    1

    0.5

    0.5

    8

    2

    1

    0.12

    0.12

    0.12

    0.12

    0.12

    0.5

    0.12

    0.12

    0.5

    0.5

    0.5

    0.5

    0.5

    1

    1

    0.5

    Kalb

    E. coli Kalb

    2006/2007 N=1542008 N=1662009 N=1602010 N=1432011 N=1612012 N=2872013 N=2502014 N=2842015 N=1692016 N=114

    Ampicillin687076.376.979.776.377.671.568.666.7

    Amox/Clav18161519.617.41518.821.52610.5

    Cephalothin443741.348.342.446.439.44243

    Chloramph495150.659.455.548.1

    Gentamicin2321253539.928.640.437.722.519.3

    Tetrazyklin717168.169.275.770.474.463.759.864

    Trimeth/Sulfa445148.152.449.457.855.647.242.639.5

    Summe

    n=1541661601431732872502841691141900

    2006/2007 N=1542008 N=1662009 N=1602010 N=1432011 N=1612012 N=2872013 N=2502014 N=2842015 N=1692016 N=114

    Imipenemn.g.n.g.n.g.n.g.n.g.0.250.250.250.250.25

    Colistin0.50.50.5121120.50.5

    Nalidixinsäure256256256256256256256256256256

    Ciprofloxacinn.g.n.g.n.g.n.g.n.g.3232323232

    Enrofloxacin32323232323232323232

    Cefotaxim1163264646464646464

    Ceftiofur264128128128128128128128128

    Kalb

    2006/2007 N=154

    2008 N=166

    2009 N=160

    2010 N=143

    2011 N=161

    2012 N=287

    2013 N=250

    resistente Stämme [%]Achsentitel

    ESBL

    2006/2007 N=154

    2008 N=166

    2009 N=160

    2010 N=143

    2011 N=161

    2012 N=287

    2013 N=250

    2014 N=284

    2015 N=169

    2016 N=114

    [%] resistente Stämme

    Tabelle2

    2006/2007 N=154

    2008 N=166

    2009 N=160

    2010 N=143

    2011 N=161

    2012 N=287

    2013 N=250

    2014 N=284

    2015 N=169

    2016 N=114

    log2 MHK90-Wert

    Ferkel

    ESBL Kalb

    JahrKalbSchweinGeflügel

    2006/200772.30.2

    20081141.4

    2009193.81.8

    2010183.91.4

    201125.410.63.6

    2012207.92.3

    201329.20.6

    2014340.6

    201526.75.51

    201629.83.73.6

    Ferkel

    2006/2007

    2008

    2009

    2010

    2011

    2012

    2013

    2014

    2015

    2016

    Prävalenz ESBL bildender E. coli [%]

    Pute

    Masthahn

    E. coliFerkel

    2006/2007 N=3452008 N=2402009 N=1242010 N=1562011 N=1832012 N=1502015 N=1342016 N=133

    Ampicillin62676971.475.47457.562.4

    Amox/Clav32211.32.21.330

    Cephalothin27191928.623.719.421.1

    Chloramphenicol31262724.232.822.7

    Gentamicin106111310.911.32.26.8

    Tetrazyklin80737778.979.272.759.762.4

    Trimeth/Sulfa50506155.9595643.351.1

    Summe

    n=3452401241561831501341331465

    2006/2007 N=3452008 N=2402009 N=1242010 N=1562011 N=1832012 N=1502015 N=1342016 N=133

    Colistin40.5488880.5

    Nalidixinsäure128256256128128256256128

    Ciprofloxacinn.g.n.g.n.g.n.g.n.g.40.50.5

    Enrofloxacin0.5110.50.5821

    Cefotaxim0.120.120.120.120.120.50.120.12

    Ceftiofur0.50.50.50.50.5110.5

    Masthahn

    2006/2007 N=345

    2008 N=240

    2009 N=124

    2010 N=156

    2011 N=183

    2012 N=150

    2015 N=134

    2016 N=133

    [%] resistente Stämme

    Colistin

    2006/2007 N=345

    2008 N=240

    2009 N=124

    2010 N=156

    2011 N=183

    2012 N=150

    2015 N=134

    2016 N=133

    log2 MHK90-Wert

    E. coli PutePutealle Indikationen

    2006/2007 N=1662006/2007 N=1662008 N=1332009 N=852010 N=952011 N=1252012 N=1592013 N=1092014 N=1102015 N=1142016 N=96

    Ampicillin61.961.965.473.542.159.749.7334033.343.8

    Amoxi/Clav2.42.41.55.31.151.30.91.82.63.1

    Cephalothin42.842.836.833.422.1208.314.513.215.6

    Chloramph14.914.921.126.621.125.818.922

    Enrofloxacin334.504.21.51.35.56.46.15.2

    Gentamicin1.81.82.32.311.613.68.803.72.66.3

    Tetrazyklin70.270.262.452.836.84827.716.537.315.825

    Trimet/Sulfa35.735.721.821.521.122.425.88.330713.5

    n=166166133859512515910911011496

    2006/2007 N=1662008 N=1332009 N=852010 N=952011 N=1252012 N=1592013 N=1092014 N=1102015 N=1142016 N=96

    Imipenemn.g.n.g.n.g.n.g.0.250.250.250.250.250.25

    Colistin0.50.580.588120.50.5

    Nalidixinsäure256128128256256256128256128256

    Ciprofloxacinn.g.n.g.n.g.n.g.0.250.50.50.50.50.5

    Cefotaxim0.120.120.120.120.120.120.120.120.120.12

    Ceftiofur0.50.50.50.50.50.50.50.50.50.5

    2006/2007 N=166

    2006/2007 N=166

    2008 N=133

    2009 N=85

    2010 N=95

    2011 N=125

    2012 N=159

    2013 N=109

    2014 N=110

    2015 N=114

    2016 N=96

    [%] resistente Stämme

    2006/2007 N=166

    2008 N=133

    2009 N=85

    2010 N=95

    2011 N=125

    2012 N=159

    2013 N=109

    2014 N=110

    2015 N=114

    2016 N=96

    log2 MHK90-Wert

    E. coliMasthahn

    2006/2007 N=302008 N=212009 N=292010 N=422011 N=742012 N=352013 N=382014 N=312015 N=1092016 N=77

    Ampicillin6343525035.642.935.838.73335.1

    Amoxi/Clav1710311.91.411.4001.86.5

    Cephalothin37242723.825.915.86.56.415.6

    Chloramph10537.16.88.617.6

    Enrofloxacin3539.59.65.75.39.76.42.6

    Gentamicin3004.89.614.37.93.23.77.8

    Tetrazyklin40242133.335.634.323.735.516.518.2

    Trimet/Sulfa4314301916.414.318.425.823.916.9

    n=302129427435383110977486

    2006/2007 N=302008 N=212009 N=292010 N=422011 N=742012 N=352013 N=382014 N=312015 N=1092016 N=77

    Ceftiofur10.50.540.5160.50.50.50.5

    Cefotaxim0.50.120.1240.12160.120.120.120.25

    Nalidixinsäure256256256256256256256256256128

    Ciprofloxacinn.g.n.g.n.g.n.g.n.g.0.50.540.50.5

    Colistin0.50.50.5111110.50.5

    0.0150.030.060.120.250.51248163264

    log2

    -6-5-4-3-2-10123456

    2006/2007 N=302008 N=212009 N=292010 N=422011 N=742012 N=352013 N=382014 N=312015 N=109

    Ceftiofur0-1-12-14-1-1-1

    Cefotaxim-1-3-32-34-3-3-3

    Nalidixinsäure888888888

    Ciprofloxacinn.g.n.g.n.g.n.g.n.g.-1-12-1

    Colistin-1-1-100000-1

    2006/2007 N=30

    2008 N=21

    2009 N=29

    2010 N=42

    2011 N=74

    2012 N=35

    2013 N=38

    2014 N=31

    2015 N=109

    2016 N=77

    [%] resistente Stämme

    2006/2007 N=30

    2008 N=21

    2009 N=29

    2010 N=42

    2011 N=74

    2012 N=35

    2013 N=38

    2014 N=31

    2015 N=109

    2016 N=77

    log2 MHK90-Wert [mg/L]

    Tab. 1.6. Anteil mcr-1 positiver Isolate an Colistin-resistenten (E. coli)

    SchweinRindGeflügelOthers

    2004/050%0%0%0%

    2005/060%0%0%0%

    2006/076%25%33%0%

    20085%0%64%0%

    200927%0%92%0%

    201047%45%77%0%

    201149%0%85%0%

    201244%0%95%100%

    2013*62%25%0%

    2014*45%57%0%

    201554%0%50%0%

    Table 1.4. Anteil Colistin-resistenter Isolate am Probeneingang

    SchweinRindGeflügelOthers

    2004/055.1%0.7%0.5%0.0%

    2005/063.5%1.1%0.4%0.0%

    2006/079.7%2.2%2.7%3.6%

    20085.7%4.5%3.3%4.5%

    20099.4%3.4%5.5%0.0%

    201012.4%2.2%4.5%0.8%

    201117.8%1.5%5.3%1.7%

    201215.8%0.7%5.2%0.0%

    2013*4.9%1.1%0.0%

    2014*2.1%2.1%1.1%

    201512.3%3.4%0.5%1.0%

    Table 1.5. Anteil mcr-1 positiver Isolate am Probeneingang (E. coli)

    SchweinRindGeflügelOthers

    2004/050.0%0.0%0.0%0.0%

    2005/060.0%0.0%0.0%0.0%

    2006/070.6%0.5%0.9%0.0%

    20080.3%0.0%2.1%0.0%

    20092.6%0.0%5.1%0.0%

    20105.8%1.0%3.4%0.0%

    20118.7%0.0%4.5%0.0%

    20126.9%0.0%5.0%1.7%

    2013*3.0%0.3%0.0%

    2014*0.9%1.2%0.0%

    20156.6%0.0%0.3%0.0%

    Schwein

    Rind

    Geflügel

    Schwein

    Rind

    Geflügel

    Schwein

    Rind

    Geflügel

  • Seite 19 Symposium Antibiotikaresistenz in der LM-Kette, Heike Kaspar Seite 19

    E. coli, Kalb, Indikation: Enteritis; 2008 - 2017

    0

    10

    20

    30

    40

    50

    60

    70

    80

    90

    100

    Ampicillin Amox/Clav Gentamicin Tetrazyklin Trimeth/Sulfa

    [%] r

    esis

    tent

    e St

    ämm

    e

    2006/2007 N=154 2008 N=166 2009 N=160 2010 N=143 2011 N=161 2012 N=287

    2013 N=250 2014 N=284 2015 N=169 2016 N=114 2017 N=114

    Diagramm1

    AmpicillinAmpicillinAmpicillinAmpicillinAmpicillinAmpicillinAmpicillinAmpicillinAmpicillinAmpicillinAmpicillin

    Amox/ClavAmox/ClavAmox/ClavAmox/ClavAmox/ClavAmox/ClavAmox/ClavAmox/ClavAmox/ClavAmox/ClavAmox/Clav

    GentamicinGentamicinGentamicinGentamicinGentamicinGentamicinGentamicinGentamicinGentamicinGentamicinGentamicin

    TetrazyklinTetrazyklinTetrazyklinTetrazyklinTetrazyklinTetrazyklinTetrazyklinTetrazyklinTetrazyklinTetrazyklinTetrazyklin

    Trimeth/SulfaTrimeth/SulfaTrimeth/SulfaTrimeth/SulfaTrimeth/SulfaTrimeth/SulfaTrimeth/SulfaTrimeth/SulfaTrimeth/SulfaTrimeth/SulfaTrimeth/Sulfa

    2006/2007 N=154

    2008 N=166

    2009 N=160

    2010 N=143

    2011 N=161

    2012 N=287

    2013 N=250

    2014 N=284

    2015 N=169

    2016 N=114

    2017 N=114

    [%] resistente Stämme

    68

    70

    76.3

    76.9

    79.7

    76.3

    77.6

    71.5

    68.6

    66.7

    75.4

    18

    16

    15

    19.6

    17.4

    15

    18.8

    21.5

    26

    10.5

    16.7

    23

    21

    25

    35

    39.9

    28.6

    40.4

    37.7

    22.5

    19.3

    24.6

    71

    71

    68.1

    69.2

    75.7

    70.4

    74.4

    63.7

    59.8

    64

    65.8

    44

    51

    48.1

    52.4

    49.4

    57.8

    55.6

    47.2

    42.6

    39.5

    44.7

    Kalb

    E. coli Kalb

    2006/2007 N=1542008 N=1662009 N=1602010 N=1432011 N=1612012 N=2872013 N=2502014 N=2842015 N=1692016 N=1142017 N=114

    Ampicillin687076.376.979.776.377.671.568.666.775.4

    Amox/Clav18161519.617.41518.821.52610.516.7

    Gentamicin2321253539.928.640.437.722.519.324.6

    Tetrazyklin717168.169.275.770.474.463.759.86465.8

    Trimeth/Sulfa445148.152.449.457.855.647.242.639.544.7

    Summe

    n=1541661601431732872502841691141142014

    2006/2007 N=1542008 N=1662009 N=1602010 N=1432011 N=1612012 N=2872013 N=2502014 N=2842015 N=1692016 N=1142017 N=114

    Imipenemn.g.n.g.n.g.n.g.n.g.0.250.250.250.250.250.25

    Colistin0.50.50.5121120.50.50.5

    Nalidixinsäure256256256256256256256256256256256

    Ciprofloxacinn.g.n.g.n.g.n.g.n.g.323232323232

    Enrofloxacin3232323232323232323232

    Cefotaxim116326464646464646464

    Ceftiofur264128128128128128128128128128

    Kalb

    2006/2007 N=154

    2008 N=166

    2009 N=160

    2010 N=143

    2011 N=161

    2012 N=287

    2013 N=250

    resistente Stämme [%]Achsentitel

    ESBL

    2006/2007 N=154

    2008 N=166

    2009 N=160

    2010 N=143

    2011 N=161

    2012 N=287

    2013 N=250

    2014 N=284

    2015 N=169

    2016 N=114

    2017 N=114

    [%] resistente Stämme

    Tabelle2

    2006/2007 N=154

    2008 N=166

    2009 N=160

    2010 N=143

    2011 N=161

    2012 N=287

    2013 N=250

    2014 N=284

    2015 N=169

    2016 N=114

    2017 N=114

    log2 MHK90-Wert

    Ferkel

    ESBL Kalb

    JahrKalbSchweinGeflügel

    2006/200772.30.2

    20081141.4

    2009193.81.8

    2010183.91.4

    201125.410.63.6

    2012207.92.3

    201329.20.6

    2014340.6

    201526.75.51

    201629.83.73.6

    Ferkel

    2006/2007

    2008

    2009

    2010

    2011

    2012

    2013

    2014

    2015

    2016

    Prävalenz ESBL bildender E. coli [%]

    Pute

    Masthahn

    E. coliFerkel

    2006/2007 N=3452008 N=2402009 N=1242010 N=1562011 N=1832012 N=1502015 N=1342016 N=1332017 N=118

    Ampicillin62676971.475.47457.562.462.7

    Amox/Clav32211.32.21.3303.4

    Chloramphenicol31262724.232.822.7

    Gentamicin106111310.911.32.26.87.7

    Tetrazyklin80737778.979.272.759.762.455.6

    Trimeth/Sulfa50506155.9595643.351.145.3

    Summe

    n=3452401241561831501341331181583

    2006/2007 N=3452008 N=2402009 N=1242010 N=1562011 N=1832012 N=1502015 N=1342016 N=1332017 N=118

    Imipenemn.g.n.g.n.g.n.g.n.g.0.250.250.250.25

    Colistin40.5488880.54

    Nalidixinsäure128256256128128256256128128

    Ciprofloxacinn.g.n.g.n.g.n.g.n.g.40.50.50.5

    Enrofloxacin0.5110.50.58211

    Cefotaxim0.120.120.120.120.120.50.120.120.12

    Ceftiofur0.50.50.50.50.5110.50.5

    Masthahn

    2006/2007 N=345

    2008 N=240

    2009 N=124

    2010 N=156

    2011 N=183

    2012 N=150

    2015 N=134

    2016 N=133

    2017 N=118

    [%] resistente Stämme

    Colistin

    2006/2007 N=345

    2008 N=240

    2009 N=124

    2010 N=156

    2011 N=183

    2012 N=150

    2015 N=134

    2016 N=133

    2017 N=118

    log2 MHK90-Wert

    E. coli PutePutealle Indikationen

    2006/2007 N=1662006/2007 N=1662008 N=1332009 N=852010 N=952011 N=1252012 N=1592013 N=1092014 N=1102015 N=1142016 N=962017 N=64

    Ampicillin61.961.965.473.542.159.749.7334033.343.845.3

    Amoxi/Clav2.42.41.55.31.151.30.91.82.63.10

    Cephalothin42.842.836.833.422.1208.314.513.215.626.6

    Chloramph14.914.921.126.621.125.818.922

    Enrofloxacin334.504.21.51.35.56.46.15.26.3

    Gentamicin1.81.82.32.311.613.68.803.72.66.39.4

    Tetrazyklin70.270.262.452.836.84827.716.537.315.82523.4

    Trimet/Sulfa35.735.721.821.521.122.425.88.330713.510.9

    n=166166133859512515910911011496641422

    2006/2007 N=1662008 N=1332009 N=852010 N=952011 N=1252012 N=1592013 N=1092014 N=1102015 N=1142016 N=962017 N=64

    Imipenemn.g.n.g.n.g.n.g.0.250.250.250.250.250.250.25

    Colistin0.50.580.588120.50.50.5

    Nalidixinsäure256128128256256256128256128256128

    Ciprofloxacinn.g.n.g.n.g.n.g.0.250.50.50.50.50.50.5

    Cefotaxim0.120.120.120.120.120.120.120.120.120.120.12

    Ceftiofur0.50.50.50.50.50.50.50.50.50.50.5

    2006/2007 N=166

    2006/2007 N=166

    2008 N=133

    2009 N=85

    2010 N=95

    2011 N=125

    2012 N=159

    2013 N=109

    2014 N=110

    2015 N=114

    2016 N=96

    2017 N=64

    [%] resistente Stämme

    2006/2007 N=166

    2008 N=133

    2009 N=85

    2010 N=95

    2011 N=125

    2012 N=159

    2013 N=109

    2014 N=110

    2015 N=114

    2016 N=96

    2017 N=64

    log2 MHK90-Wert

    E. coliMasthahn

    2006/2007 N=302008 N=212009 N=292010 N=422011 N=742012 N=352013 N=382014 N=312015 N=1092016 N=772017 N=45

    Ampicillin6343525035.642.935.838.73335.144.4

    Amoxi/Clav1710311.91.411.4001.86.52.2

    Cephalothin37242723.825.915.86.56.415.615.6

    Chloramph10537.16.88.617.6

    Enrofloxacin3539.59.65.75.39.76.42.62.2

    Gentamicin3004.89.614.37.93.23.77.82.2

    Tetrazyklin40242133.335.634.323.735.516.518.226.7

    Trimet/Sulfa4314301916.414.318.425.823.916.920

    n=30212942743538311097745531

    2006/2007 N=302008 N=212009 N=292010 N=422011 N=742012 N=352013 N=382014 N=312015 N=1092016 N=772017 N=45

    Ceftiofur10.50.540.5160.50.50.50.50.5

    Cefotaxim0.50.120.1240.12160.120.120.120.250.12

    Nalidixinsäure256256256256256256256256256128256

    Ciprofloxacinn.g.n.g.n.g.n.g.n.g.0.50.540.50.50.5

    Colistin0.50.50.5111110.50.50.5

    0.0150.030.060.120.250.51248163264

    log2

    -6-5-4-3-2-10123456

    2006/2007 N=302008 N=212009 N=292010 N=422011 N=742012 N=352013 N=382014 N=312015 N=109

    Ceftiofur0-1-12-14-1-1-1

    Cefotaxim-1-3-32-34-3-3-3

    Nalidixinsäure888888888

    Ciprofloxacinn.g.n.g.n.g.n.g.n.g.-1-12-1

    Colistin-1-1-100000-1

    2006/2007 N=30

    2008 N=21

    2009 N=29

    2010 N=42

    2011 N=74

    2012 N=35

    2013 N=38

    2014 N=31

    2015 N=109

    2016 N=77

    2017 N=45

    [%] resistente Stämme

    2006/2007 N=30

    2008 N=21

    2009 N=29

    2010 N=42

    2011 N=74

    2012 N=35

    2013 N=38

    2014 N=31

    2015 N=109

    2016 N=77

    2017 N=45

    log2 MHK90-Wert

    Tab. 1.6. Anteil mcr-1 positiver Isolate an Colistin-resistenten (E. coli)

    SchweinRindGeflügelOthers

    2004/050%0%0%0%

    2005/060%0%0%0%

    2006/076%25%33%0%

    20085%0%64%0%

    200927%0%92%0%

    201047%45%77%0%

    201149%0%85%0%

    201244%0%95%100%

    2013*62%25%0%

    2014*45%57%0%

    201554%0%50%0%

    Table 1.4. Anteil Colistin-resistenter Isolate am Probeneingang

    SchweinRindGeflügelOthers

    2004/055.1%0.7%0.5%0.0%

    2005/063.5%1.1%0.4%0.0%

    2006/079.7%2.2%2.7%3.6%

    20085.7%4.5%3.3%4.5%

    20099.4%3.4%5.5%0.0%

    201012.4%2.2%4.5%0.8%

    201117.8%1.5%5.3%1.7%

    201215.8%0.7%5.2%0.0%

    2013*4.9%1.1%0.0%

    2014*2.1%2.1%1.1%

    201512.3%3.4%0.5%1.0%

    Table 1.5. Anteil mcr-1 positiver Isolate am Probeneingang (E. coli)

    SchweinRindGeflügelOthers

    2004/050.0%0.0%0.0%0.0%

    2005/060.0%0.0%0.0%0.0%

    2006/070.6%0.5%0.9%0.0%

    20080.3%0.0%2.1%0.0%

    20092.6%0.0%5.1%0.0%

    20105.8%1.0%3.4%0.0%

    20118.7%0.0%4.5%0.0%

    20126.9%0.0%5.0%1.7%

    2013*3.0%0.3%0.0%

    2014*0.9%1.2%0.0%

    20156.6%0.0%0.3%0.0%

    Schwein

    Rind

    Geflügel

    Schwein

    Rind

    Geflügel

    Schwein

    Rind

    Geflügel

  • Seite 20 Symposium Antibiotikaresistenz in der LM-Kette, Heike Kaspar

    Ergebnisse E. coli, Kalb, MHK90-Daten Indikation: Enteritis; 2006 - 2017

    Ciprofloxacin ab 2012 untersucht

    Diagramm1

    ColistinColistinColistinColistinColistinColistinColistinColistinColistinColistinColistin

    NalidixinsäureNalidixinsäureNalidixinsäureNalidixinsäureNalidixinsäureNalidixinsäureNalidixinsäureNalidixinsäureNalidixinsäureNalidixinsäureNalidixinsäure

    CiprofloxacinCiprofloxacinCiprofloxacinCiprofloxacinCiprofloxacinCiprofloxacinCiprofloxacinCiprofloxacinCiprofloxacinCiprofloxacinCiprofloxacin

    EnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacin

    CefotaximCefotaximCefotaximCefotaximCefotaximCefotaximCefotaximCefotaximCefotaximCefotaximCefotaxim

    CeftiofurCeftiofurCeftiofurCeftiofurCeftiofurCeftiofurCeftiofurCeftiofurCeftiofurCeftiofurCeftiofur

    2006/2007 N=154

    2008 N=166

    2009 N=160

    2010 N=143

    2011 N=161

    2012 N=287

    2013 N=250

    2014 N=284

    2015 N=169

    2016 N=114

    2017 N=114

    log2 MHK90-Wert

    0.5

    0.5

    0.5

    1

    2

    1

    1

    2

    0.5

    0.5

    0.5

    256

    256

    256

    256

    256

    256

    256

    256

    256

    256

    256

    0

    0

    0

    0

    0

    32

    32

    32

    32

    32

    32

    32

    32

    32

    32

    32

    32

    32

    32

    32

    32

    32

    1

    16

    32

    64

    64

    64

    64

    64

    64

    64

    64

    2

    64

    128

    128

    128

    128

    128

    128

    128

    128

    128

    Kalb

    E. coli Kalb

    2006/2007 N=1542008 N=1662009 N=1602010 N=1432011 N=1612012 N=2872013 N=2502014 N=2842015 N=1692016 N=1142017 N=114

    Ampicillin687076.376.979.776.377.671.568.666.775.4

    Amox/Clav18161519.617.41518.821.52610.516.7

    Cephalothin443741.348.342.446.439.4424349.1

    Chloramph495150.659.455.548.1

    Gentamicin2321253539.928.640.437.722.519.324.6

    Tetrazyklin717168.169.275.770.474.463.759.86465.8

    Trimeth/Sulfa445148.152.449.457.855.647.242.639.544.7

    Summe

    n=1541661601431732872502841691141142014

    2006/2007 N=1542008 N=1662009 N=1602010 N=1432011 N=1612012 N=2872013 N=2502014 N=2842015 N=1692016 N=1142017 N=114

    Colistin0.50.50.5121120.50.50.5

    Nalidixinsäure256256256256256256256256256256256

    Ciprofloxacinn.g.n.g.n.g.n.g.n.g.323232323232

    Enrofloxacin3232323232323232323232

    Cefotaxim116326464646464646464

    Ceftiofur264128128128128128128128128128

    Kalb

    2006/2007 N=154

    2008 N=166

    2009 N=160

    2010 N=143

    2011 N=161

    2012 N=287

    2013 N=250

    resistente Stämme [%]Achsentitel

    ESBL

    2006/2007 N=154

    2008 N=166

    2009 N=160

    2010 N=143

    2011 N=161

    2012 N=287

    2013 N=250

    2014 N=284

    2015 N=169

    2016 N=114

    2017 N=114

    [%] resistente Stämme

    Tabelle2

    2006/2007 N=154

    2008 N=166

    2009 N=160

    2010 N=143

    2011 N=161

    2012 N=287

    2013 N=250

    2014 N=284

    2015 N=169

    2016 N=114

    2017 N=114

    log2 MHK90-Wert

    Ferkel

    ESBL Kalb

    JahrKalbSchweinGeflügel

    2006/200772.30.2

    20081141.4

    2009193.81.8

    2010183.91.4

    201125.410.63.6

    2012207.92.3

    201329.20.6

    2014340.6

    201526.75.51

    201629.83.73.6

    Ferkel

    2006/2007

    2008

    2009

    2010

    2011

    2012

    2013

    2014

    2015

    2016

    Prävalenz ESBL bildender E. coli [%]

    Pute

    Masthahn

    E. coliFerkel

    2006/2007 N=3452008 N=2402009 N=1242010 N=1562011 N=1832012 N=1502015 N=1342016 N=1332017 N=118

    Ampicillin62676971.475.47457.562.462.7

    Amox/Clav32211.32.21.3303.4

    Chloramphenicol31262724.232.822.7

    Gentamicin106111310.911.32.26.87.7

    Tetrazyklin80737778.979.272.759.762.455.6

    Trimeth/Sulfa50506155.9595643.351.145.3

    Summe

    n=3452401241561831501341331181583

    2006/2007 N=3452008 N=2402009 N=1242010 N=1562011 N=1832012 N=1502015 N=1342016 N=1332017 N=118

    Imipenemn.g.n.g.n.g.n.g.n.g.0.250.250.250.25

    Colistin40.5488880.54

    Nalidixinsäure128256256128128256256128128

    Ciprofloxacinn.g.n.g.n.g.n.g.n.g.40.50.50.5

    Enrofloxacin0.5110.50.58211

    Cefotaxim0.120.120.120.120.120.50.120.120.12

    Ceftiofur0.50.50.50.50.5110.50.5

    Masthahn

    2006/2007 N=345

    2008 N=240

    2009 N=124

    2010 N=156

    2011 N=183

    2012 N=150

    2015 N=134

    2016 N=133

    2017 N=118

    [%] resistente Stämme

    Colistin

    2006/2007 N=345

    2008 N=240

    2009 N=124

    2010 N=156

    2011 N=183

    2012 N=150

    2015 N=134

    2016 N=133

    2017 N=118

    log2 MHK90-Wert

    E. coli PutePutealle Indikationen

    2006/2007 N=1662006/2007 N=1662008 N=1332009 N=852010 N=952011 N=1252012 N=1592013 N=1092014 N=1102015 N=1142016 N=962017 N=64

    Ampicillin61.961.965.473.542.159.749.7334033.343.845.3

    Amoxi/Clav2.42.41.55.31.151.30.91.82.63.10

    Cephalothin42.842.836.833.422.1208.314.513.215.626.6

    Chloramph14.914.921.126.621.125.818.922

    Enrofloxacin334.504.21.51.35.56.46.15.26.3

    Gentamicin1.81.82.32.311.613.68.803.72.66.39.4

    Tetrazyklin70.270.262.452.836.84827.716.537.315.82523.4

    Trimet/Sulfa35.735.721.821.521.122.425.88.330713.510.9

    n=166166133859512515910911011496641422

    2006/2007 N=1662008 N=1332009 N=852010 N=952011 N=1252012 N=1592013 N=1092014 N=1102015 N=1142016 N=962017 N=64

    Imipenemn.g.n.g.n.g.n.g.0.250.250.250.250.250.250.25

    Colistin0.50.580.588120.50.50.5

    Nalidixinsäure256128128256256256128256128256128

    Ciprofloxacinn.g.n.g.n.g.n.g.0.250.50.50.50.50.50.5

    Cefotaxim0.120.120.120.120.120.120.120.120.120.120.12

    Ceftiofur0.50.50.50.50.50.50.50.50.50.50.5

    2006/2007 N=166

    2006/2007 N=166

    2008 N=133

    2009 N=85

    2010 N=95

    2011 N=125

    2012 N=159

    2013 N=109

    2014 N=110

    2015 N=114

    2016 N=96

    2017 N=64

    [%] resistente Stämme

    2006/2007 N=166

    2008 N=133

    2009 N=85

    2010 N=95

    2011 N=125

    2012 N=159

    2013 N=109

    2014 N=110

    2015 N=114

    2016 N=96

    2017 N=64

    log2 MHK90-Wert

    E. coliMasthahn

    2006/2007 N=302008 N=212009 N=292010 N=422011 N=742012 N=352013 N=382014 N=312015 N=1092016 N=772017 N=45

    Ampicillin6343525035.642.935.838.73335.144.4

    Amoxi/Clav1710311.91.411.4001.86.52.2

    Cephalothin37242723.825.915.86.56.415.615.6

    Chloramph10537.16.88.617.6

    Enrofloxacin3539.59.65.75.39.76.42.62.2

    Gentamicin3004.89.614.37.93.23.77.82.2

    Tetrazyklin40242133.335.634.323.735.516.518.226.7

    Trimet/Sulfa4314301916.414.318.425.823.916.920

    n=30212942743538311097745531

    2006/2007 N=302008 N=212009 N=292010 N=422011 N=742012 N=352013 N=382014 N=312015 N=1092016 N=772017 N=45

    Ceftiofur10.50.540.5160.50.50.50.50.5

    Cefotaxim0.50.120.1240.12160.120.120.120.250.12

    Nalidixinsäure256256256256256256256256256128256

    Ciprofloxacinn.g.n.g.n.g.n.g.n.g.0.50.540.50.50.5

    Colistin0.50.50.5111110.50.50.5

    0.0150.030.060.120.250.51248163264

    log2

    -6-5-4-3-2-10123456

    2006/2007 N=302008 N=212009 N=292010 N=422011 N=742012 N=352013 N=382014 N=312015 N=109

    Ceftiofur0-1-12-14-1-1-1

    Cefotaxim-1-3-32-34-3-3-3

    Nalidixinsäure888888888

    Ciprofloxacinn.g.n.g.n.g.n.g.n.g.-1-12-1

    Colistin-1-1-100000-1

    2006/2007 N=30

    2008 N=21

    2009 N=29

    2010 N=42

    2011 N=74

    2012 N=35

    2013 N=38

    2014 N=31

    2015 N=109

    2016 N=77

    2017 N=45

    [%] resistente Stämme

    2006/2007 N=30

    2008 N=21

    2009 N=29

    2010 N=42

    2011 N=74

    2012 N=35

    2013 N=38

    2014 N=31

    2015 N=109

    2016 N=77

    2017 N=45

    log2 MHK90-Wert

    Tab. 1.6. Anteil mcr-1 positiver Isolate an Colistin-resistenten (E. coli)

    SchweinRindGeflügelOthers

    2004/050%0%0%0%

    2005/060%0%0%0%

    2006/076%25%33%0%

    20085%0%64%0%

    200927%0%92%0%

    201047%45%77%0%

    201149%0%85%0%

    201244%0%95%100%

    2013*62%25%0%

    2014*45%57%0%

    201554%0%50%0%

    Table 1.4. Anteil Colistin-resistenter Isolate am Probeneingang

    SchweinRindGeflügelOthers

    2004/055.1%0.7%0.5%0.0%

    2005/063.5%1.1%0.4%0.0%

    2006/079.7%2.2%2.7%3.6%

    20085.7%4.5%3.3%4.5%

    20099.4%3.4%5.5%0.0%

    201012.4%2.2%4.5%0.8%

    201117.8%1.5%5.3%1.7%

    201215.8%0.7%5.2%0.0%

    2013*4.9%1.1%0.0%

    2014*2.1%2.1%1.1%

    201512.3%3.4%0.5%1.0%

    Table 1.5. Anteil mcr-1 positiver Isolate am Probeneingang (E. coli)

    SchweinRindGeflügelOthers

    2004/050.0%0.0%0.0%0.0%

    2005/060.0%0.0%0.0%0.0%

    2006/070.6%0.5%0.9%0.0%

    20080.3%0.0%2.1%0.0%

    20092.6%0.0%5.1%0.0%

    20105.8%1.0%3.4%0.0%

    20118.7%0.0%4.5%0.0%

    20126.9%0.0%5.0%1.7%

    2013*3.0%0.3%0.0%

    2014*0.9%1.2%0.0%

    20156.6%0.0%0.3%0.0%

    Schwein

    Rind

    Geflügel

    Schwein

    Rind

    Geflügel

    Schwein

    Rind

    Geflügel

  • Seite 21 Symposium Antibiotikaresistenz in der LM-Kette, Heike Kaspar Seite 21

    E. coli, Prävalenzdaten ESBL-bildender (%)

    Ergebnisse

    Diagramm1

    2006/20072006/20072006/20072006/2007

    2008200820082008

    2009200920092009

    2010201020102010

    2011201120112011

    2012201220122012

    2013201320132013

    2014201420142014

    2015201520152015

    2016201620162016

    Schwein (2013 und 2014 nicht untersucht)

    Kalb

    Geflügel

    Hund

    Prävalenz ESBL E. coli [%]

    2.3

    7

    0.2

    0

    4

    11

    1.4

    0

    3.8

    19

    1.8

    5.4

    3.9

    18

    1.4

    3.2

    10.6

    25.4

    3.6

    4.7

    7.9

    20

    2.3

    1.4

    29

    0.6

    7.8

    34

    0.6

    14.7

    5.5

    26.7

    1

    4.4

    3.7

    29.8

    3.6

    3.8

    Tabelle1

    Schwein (2013 und 2014 nicht untersucht)KalbGeflügelHund

    2006/20072.370.20

    20084111.40

    20093.8191.85.4

    20103.9181.43.2

    201110.625.43.64.7

    20127.9202.31.4

    2013290.67.8

    2014340.614.7

    20155.526.714.4

    20163.729.83.63.8

    Tabelle1

    Schwein (2013 und 2014 nicht untersucht)

    Kalb

    Geflügel

    Hund

    Prävalenz ESBL E. coli [%]

  • Seite 22 Symposium Antibiotikaresistenz in der LM-Kette, Heike Kaspar Seite 22

    Ergebnisse des Nationalen Resistenzmonitoring

    Mastitis

  • Seite 23 Symposium Antibiotikaresistenz in der LM-Kette, Heike Kaspar

    E. coli, Milchrind, Indikation: Mastitis; 2002 - 2016

    Ergebnisse

    Diagramm1

    AmpicillinAmpicillinAmpicillinAmpicillinAmpicillinAmpicillinAmpicillin

    Amoxicillin/ClavulansäureAmoxicillin/ClavulansäureAmoxicillin/ClavulansäureAmoxicillin/ClavulansäureAmoxicillin/ClavulansäureAmoxicillin/ClavulansäureAmoxicillin/Clavulansäure

    CeftiofurCeftiofurCeftiofurCeftiofurCeftiofurCeftiofurCeftiofur

    GentamicinGentamicinGentamicinGentamicinGentamicinGentamicinGentamicin

    TetracyclinTetracyclinTetracyclinTetracyclinTetracyclinTetracyclinTetracyclin

    Trimethoprim/SulfamethoxazolTrimethoprim/SulfamethoxazolTrimethoprim/SulfamethoxazolTrimethoprim/SulfamethoxazolTrimethoprim/SulfamethoxazolTrimethoprim/SulfamethoxazolTrimethoprim/Sulfamethoxazol

    2002/2003 N=258

    2004/2005 N=353

    2005/2006 N=534

    2010 N=305

    2012 N=323

    2014 N=240

    2016 N=275

    resistente Isolate [%]

    14

    15

    13.3

    13.1

    17

    18.7

    17.8

    0

    0

    0.9

    2.6

    2.5

    4.1

    3.3

    0

    1.4

    1.1

    3

    8.7

    6.6

    7.6

    2.3

    2.5

    1.1

    2

    1.5

    5

    2.9

    11.2

    14.5

    11.2

    11.5

    10.5

    16.6

    16

    12

    7.5

    6.9

    5.2

    7.4

    12.4

    12.4

    Kalb

    2008 N=1662009 N=1602010 N=1432011 N=1612012 N=2872013 N=2502014 N=2842015 N=169

    Ampicillin7076.376.979.776.377.671.568.6

    Amoxicillin/Clavulansäure161519.617.41518.821.526

    CEF3741.348.342.446.439.442

    Gentamicin21253539.928.640.437.722.5

    Tetrayclin7168.169.275.770.474.463.759.8

    Trimethoprim/Sulfamethoxazol5148.152.449.457.855.647.242.6

    n=166160143173287250284169

    Kalb

    ESBL [%]

    2006/20077

    200811

    200919

    201018

    201125.4

    201220

    201329.2

    201434

    201526

    201629.8

    Kalb

    2008 N=166

    2010 N=143

    2012 N=287

    2014 N=284

    2015 N=169

    resistente Stämme [%]

    Milchrind Mastitis

    ESBL [%]

    Prävalenz ESBL E. coli Kalb [%]

    Schwein

    Mastitis E. coli 2016

    2002/2003 N=2582004/2005 N=3532005/2006 N=5342010 N=3052012 N=3232014 N=2402016 N=275

    Ampicillin141513.313.11718.717.8

    Amoxicillin/Clavulansäure000.92.62.54.13.3

    Ceftiofur01.41.138.76.67.6

    Gentamicin2.32.51.121.552.9

    Tetracyclin11.214.511.211.510.516.616

    Trimethoprim/Sulfamethoxazol127.56.95.27.412.412.4

    n258353534305323241275

    nach CLSI VET01S 3 rd. Ed

    Schwein

    2002/2003 N=258

    2004/2005 N=353

    2005/2006 N=534

    2010 N=305

    2012 N=323

    2014 N=240

    2016 N=275

    resistente Isolate [%]

    Schwein 2

    E.coli Ferkel Enteritis

    2005/2006 N=3322006/2007 N=3452008 N=2402009 N=1242010 N=1602011 N=1832012 N=1502015 N=1342016 N=133

    Ampicillin5962676971.474.97457.562.4

    Amoxicillin/Clavulansäure132211.32.11.330

    Cephalothin2227191928.623.719.421.1

    CHL2731262724.2

    Gentamicin6106111310.711.32.26.8

    Tetracyclin7880737778.979.172.759.762.4

    Trimethoprim/Sulfamethoxazol5250506155.958.35643.351.1

    n=332345240124160183150134133

    Schwein

    ESBL [%]

    2006/20072.3

    20084

    20093.8

    20103.9

    201110.6

    20127.9

    20155.5

    20163.7

    Schwein 2

    2005/2006 N=332

    2008 N=240

    2010 N=160

    2012 N=150

    2015 N=134

    2016 N=133

    resistente Stämme [%]

    Legehenne

    ESBL [%]

    Prävalenz ESBL E. coli Schwein [%]

    masthahn

    E. coliFerkel

    2005/20062006/2007200820092010201120122015

    AMP5962676971.4

    AUG132211.3

    CEP2227191928.6

    CHL2731262724.2

    GEN61061113

    TET7880737778.9

    SXT5250506155.9

    n=332345240124160

    E. coliFerkel

    2006/2007200820092010

    AMP62676971.4

    AUG32211.3

    CEP27191928.6

    CHL31262724.2

    GEN1061113

    TET80737778.9

    SXT50506155.9

    n=345240124160

    E. coliFerkel

    2006/2007 N=3452008 N=2402009 N=1242010 N=1602011 N=116

    AMP62676971.470.7

    AMC32211.310.7

    CEF27191928.631.8

    CHL31262724.233.3

    GEN106111312

    TET80737778.978.6

    SXT50506155.957.3

    n=345240124160116

    masthahn

    00000

    % resistente Stämme

    Pute

    0000

    % resistente Stämme

    Kleintier GIT

    00000

    % resistant strains

    Kleintier UTI

    2006/2007 N=1592008 N=1762009 N=722010 N=1032011 N=1622012 N=1962013 N=1952014 N=1762015 N=1662016 N=132

    Ampicillin19321721.723.814.414.916.515.720.5

    Amoxicillin/Clavulansäure1000.9500.5000

    Cephalothin161587.516.74.1464.5

    CHL4665.851

    Enrofloxacin32014.31.53.61.134.5

    Gentamicin6201.93.13.11.50.62.40.8

    Tetracyclin27311515.521.714.913.81714.521.2

    Trimethoprim/Sulfamethoxazol91537.86.83.63.69.14.83.8

    n=15917672103162196195176166132

    Kleintier UTI

    2006/2007 N=159

    2008 N=176

    2010 N=103

    2012 N=196

    2014 N=176

    2015 N=166

    2016 N=132

    resistente Stämme [%]

    Hund UTI

    2006/2007 N=302008 N=212009 N=292010 N=422011 N=742012 N=352013 N=382014 N=312015 N=1092016 N=77

    Ampicillin6343525035.642.935.838.73335.1

    Amoxicillin/Clavulansäure1710311.91.411.4001.86.5

    Cephalothin37242723.825.915.86.56.415.6

    CHL10537.16.88.617.6

    Enrofloxacin3539.59.65.75.39.76.42.6

    Gentamicin3004.89.614.37.93.23.77.8

    Tetracyclin40242133.335.634.323.735.516.518.2

    Trimethoprim/Sulfamethoxazol4314301916.414.318.425.823.916.9

    n=302129427435383110977

    Geflügel

    ESBL [%]

    2006/20070.2

    20081.4

    20091.8

    20101.4

    20113.6

    20122.3

    20130.6

    20140.6N=321

    20151N=400

    20163.6N=305

    2010 N=422011 N=742012 N=352013 N=382014 N=31

    AMP5035.642.935.838.7

    AMC11.91.411.400

    CEF23.825.915.86.5

    CHL7.16.88.617.6

    ENR9.59.65.75.39.7

    GEN4.89.614.37.93.2

    TET33.335.634.323.735.5

    SXT1916.414.318.425.8

    n=4274353831

    Hund UTI

    2006/2007 N=30

    2008 N=21

    2010 N=42

    2012 N=35

    2014 N=31

    2015 N=109

    2016 N=77

    resistente Stämme [%]

    Hund GIT

    ESBL [%]

    Prävalenz ESBL-bildende E. coli Geflügel [%]

    Katze GIT

    2010 N=42

    2011 N=74

    2012 N=35

    2013 N=38

    2014 N=31

    resistnat strains [%]

    Katze UTI

    E. coliPutealle Indikationen

    2006/2007 N=1662008 N=1332009 N=852010 N=952011 N=1252012 N=1592013 N=1092014 N=1102015 N=1142016 N=96

    Ampicillin61.965.473.542.159.749.7334033.343.8

    Amoxicillin/Clavulansäure2.41.55.31.151.30.91.82.63.1

    Cephalothin42.836.833.422.1208.314.513.215.6

    CHL14.921.126.621.125.818.922

    Enrofloxacin34.504.21.51.35.56.46.15.2

    Gentamicin1.82.32.311.613.68.803.72.66.3

    Tetracyclin70.262.452.836.84827.716.537.315.825

    Trimethoprim/Sulfamethoxazol35.721.821.521.122.425.88.330713.5

    n=166133859512515910911011496

    E. coliPuteSeptikämie

    2006/2007 N=1242008 N=982009 N=662010 N=742011 N=632012 N=1292013 N=882014 N=1002015 N=982016 N=78

    AMP60666439.263.149.630.73935.747.4

    AMC2201.41.50.8023.13.8

    CEF43402923256.81414.319.2

    CHL13242720.319.717.120.5

    ENR2404.11.51.64.577.16.4

    GEN12510.812.37023.17.7

    TET69645935.143.124.8173516.329.5

    SXT36241725.323.125.69.1308.215.4

    n=12498667463129881009878

    E. coliPuteResp. Symptomatik

    2006/200720082009201020112012 N=282013 N=212014 N=11

    AMP6355845051.453.642.945.5

    AUG7011003.64.80

    CEP401837202014.318.2

    CHL2092621.122.928.627.3

    ENR3905.35.709.50

    GEN05015.811.417.909.1

    TET70504747.44039.314.363.6

    SXT37142626.317.128.64.830

    n=3022192035282111

    E. coliPuteSeptikämie

    2010 N=742011 N=632012 N=1292013 N=882014 N=100

    AMP39.263.149.630.739

    AMC1.41.50.802

    CEF23256.814

    CHL20.319.717.120.5

    ENR4.11.51.64.57

    GEN10.812.3702

    TET35.143.124.81735

    SXT25.323.125.69.130

    n=746312988100

    Katze UTI

    2006/2007 N=166

    2008 N=133

    2010 N=95

    2012 N=159

    2014 N=110

    2015 N=114

    2016 N=96

    resistente Stämme [%]

    2006/2007 N=124

    2008 N=98

    2009 N=66

    2010 N=74

    2011 N=63

    2012 N=129

    2013 N=88

    2014 N=100

    2015 N=98

    2016 N=78

    resistente Stämme [%]

    2006/2007

    2008

    2009

    2010

    2011

    2012 N=28

    2013 N=21

    2014 N=11

    resistente Stämme [%]

    2010 N=74

    2011 N=63

    2012 N=129

    2013 N=88

    2014 N=100

    resistant strains [%]

    E. coliKleintierGIT

    2006/2007 N=962008 N=382009 N=252010 N=272011 N=182012 N=182013 N=172014 N=652015 N=472016 N=13

    AMP21.926.32018.544.435.338.531.9

    AMC2347.4011.107.72.1

    CHL1580190

    GEN Hund006.604.8011.12.68

    GEN Katze04.800012.504.5

    TET15292411.128.644.423.521.525.5

    SXT1313203.71927.823.521.521.3

    n=9638252718181747

    Hund 5417151710109258

    Katze 42211010888225

    alle E. coli

    Hund

    ESBL [%]

    2006/20070

    20080

    20095.4

    20103.2

    20114.7

    20121.4

    20137

    201414.7

    20154.4

    20163.8

    2006/2007 N=96

    2008 N=38

    2009 N=25

    2010 N=27

    2014 N=65

    2015 N=47

    resistente Stämme {%]

    ESBL [%]

    Prävalenz ESBL E. coli Hund [%]

    E. coliKleintierUGT

    2006/2007 N=632008 N=292009 N=132010 N=242011 N=322012 N=332013 N=372014 N=322015 N=452016 N=59

    Ampicillin2735.738.921.731.333.337.828.133.337.3*nicht sensibel (>8)

    Amoxicillin/Clavulansäure15.921.428.606.2512.210.818.717.813.6*nicht sensibel (>8)

    CEF191126.712.512.516.216.9

    CHL5704.218.824.6

    Gentamicin/Hund00904.313.601913.34.5

    Gentamicin/Katze0004.200006.76.7

    Enrofloxacin/Hund21113621.48.722.719.216.116.720.5

    Marbofloxacin/Hund*11.122.716.216.116.720.5

    Tetracyclin21329.112.521.927.335.112.931.123.7

    Trimethoprim/Sulfamethoxazol161844.420.818.818.224.316.12022

    n=63291324323337324559

    Hund 4319112322263044

    Katze 2092911111515

    2006/2007 N=63

    2008 N=29

    2009 N=13

    2010 N=24

    2014 N=32

    2015 N=45

    2016 N=59

    resistente Stämme [%]

    E. coliUGT

    2008 N=192010 N=132012 N=332014 N=192015 N=55

    AMP31.615.433.336.836.4

    AMC15.8012.126.316.4

    ENR10.57.721.216.712.7

    GEN009.11910.9

    MAR21.2012.7

    TET26.37.727.31127.3

    SXT15.823.118.216.723.6

    n=1913331955

    alle E. coli

    Hund

    ESBL [%]

    2006/20070

    20080

    20095.4

    20103.2

    20114.7

    20121.4

    20137

    2008 N=19

    2010 N=13

    2012 N=33

    2014 N=19

    2015 N=55

    resistente Stämme {%]

    2006/2007

    2008

    2009

    2010

    2011

    2012

    2013

    ESBL [%]

    Prävalenz ESBL E. coli Hund [%]

    0

    0

    5.4

    3.2

    4.7

    1.4

    7

    E. coliGIT

    2008 N=172010 N=172013 N=92014 N=382015 N=25

    AMP35.511.833.347.432

    AMC05.907.94

    GEN0011.12.68

    TET47.15.922.221.116

    SXT0022.226.316

    n=22.227181817

    alle E. coli

    Hund

    ESBL [%]

    2006/20070

    20080

    20095.4

    20103.2

    20114.7

    20121.4

    20137

    2008 N=17

    2010 N=17

    2013 N=9

    2014 N=38

    2015 N=25

    resistente Stämme {%]

    2006/2007

    2008

    2009

    2010

    2011

    2012

    2013

    ESBL [%]

    Prävalenz ESBL E. coli Hund [%]

    0

    0

    5.4

    3.2

    4.7

    1.4

    7

  • Seite 24 Symposium Antibiotikaresistenz in der LM-Kette, Heike Kaspar

    Wirkstoffe, für die keine klinischen Grenzwerte vorhanden sind

    Studienjahr

    MHK90 [mg/L] 2004/ 2005

    2005/ 2006 2010 2012 2014 2016

    Cefotaxim - 0,12 0,12 8 0,12 0,5

    Cefquinom 0,12 0,06 0,12 8 0,12 0,5

    Colistin 0,25 0,5 1 1 2 0,5

    Doxycyclin 16 8 8 8 16 16

    Enrofloxacin 0,06 0,06 0,06 0,06 0,06 0,06

    Nalidixinsäure 4 4 4 4 4 8

    N = 353 534 305 323 241 275

    E. coli, Milchrind, Indikation: Mastitis, MHK90-Daten; 2002 - 2016

    Ergebnisse

  • Seite 25 Symposium Antibiotikaresistenz in der LM-Kette, Heike Kaspar

    S. aureus, Milchrind, Indikation: Mastitis; 2008 - 2015

    Ergebnisse

  • Seite 26 Symposium Antibiotikaresistenz in der LM-Kette, Heike Kaspar

    Ergebnisse

    S. aureus, Milchrind, Indikation: Mastitis, MHK90-Daten; 2008 - 2015

    MHK90 [mg/L] Studienjahr

    Wirkstoffe, für die keine klinischen Grenzwerte vorhanden sind

    2008 2009 2011 2013 2015

    Cefoperazon 2 2 2 2 4

    Cefotaxim 2 2 2 4 4

    Cefquinom 1 1 1 1 1

    Clindamycin 0,12 0,25 0,25 0,25 0,25

    Enrofloxacin 0,25 0,25 0,25 0,25 0,5

    N = 394 210 346 205 363

  • Seite 27 Symposium Antibiotikaresistenz in der LM-Kette, Heike Kaspar

    Ergebnisse des Nationalen Resistenzmonitoring

    Geflügel

  • Seite 28 Symposium Antibiotikaresistenz in der LM-Kette, Heike Kaspar

    E. coli, Pute, verschiedene Indikationen; 2006 - 2017

    Ergebnisse

    Diagramm1

    AmpicillinAmpicillinAmpicillinAmpicillinAmpicillinAmpicillinAmpicillinAmpicillinAmpicillinAmpicillinAmpicillinAmpicillin

    Amoxi/ClavAmoxi/ClavAmoxi/ClavAmoxi/ClavAmoxi/ClavAmoxi/ClavAmoxi/ClavAmoxi/ClavAmoxi/ClavAmoxi/ClavAmoxi/ClavAmoxi/Clav

    ChloramphChloramphChloramphChloramphChloramphChloramphChloramphChloramphChloramphChloramphChloramphChloramph

    EnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacin

    GentamicinGentamicinGentamicinGentamicinGentamicinGentamicinGentamicinGentamicinGentamicinGentamicinGentamicinGentamicin

    TetrazyklinTetrazyklinTetrazyklinTetrazyklinTetrazyklinTetrazyklinTetrazyklinTetrazyklinTetrazyklinTetrazyklinTetrazyklinTetrazyklin

    Trimet/SulfaTrimet/SulfaTrimet/SulfaTrimet/SulfaTrimet/SulfaTrimet/SulfaTrimet/SulfaTrimet/SulfaTrimet/SulfaTrimet/SulfaTrimet/SulfaTrimet/Sulfa

    2006/2007 N=166

    2006/2007 N=166

    2008 N=133

    2009 N=85

    2010 N=95

    2011 N=125

    2012 N=159

    2013 N=109

    2014 N=110

    2015 N=114

    2016 N=96

    2017 N=64

    [%] resistente Stämme

    61.9

    65.4

    73.5

    42.1

    59.7

    49.7

    33

    40

    33.3

    43.8

    45.3

    2.4

    1.5

    5.3

    1.1

    5

    1.3

    0.9

    1.8

    2.6

    3.1

    0

    14.9

    21.1

    26.6

    21.1

    25.8

    18.9

    22

    3

    4.5

    0

    4.2

    1.5

    1.3

    5.5

    6.4

    6.1

    5.2

    6.3

    1.8

    2.3

    2.3

    11.6

    13.6

    8.8

    0

    3.7

    2.6

    6.3

    9.4

    70.2

    62.4

    52.8

    36.8

    48

    27.7

    16.5

    37.3

    15.8

    25

    23.4

    35.7

    21.8

    21.5

    21.1

    22.4

    25.8

    8.3

    30

    7

    13.5

    10.9

    Kalb

    E. coli Kalb

    2006/2007 N=1542008 N=1662009 N=1602010 N=1432011 N=1612012 N=2872013 N=2502014 N=2842015 N=1692016 N=1142017 N=114

    Ampicillin687076.376.979.776.377.671.568.666.775.4

    Amox/Clav18161519.617.41518.821.52610.516.7

    Cephalothin443741.348.342.446.439.4424349.1

    Chloramph495150.659.455.548.1

    Gentamicin2321253539.928.640.437.722.519.324.6

    Tetrazyklin717168.169.275.770.474.463.759.86465.8

    Trimeth/Sulfa445148.152.449.457.855.647.242.639.544.7

    Summe

    n=1541661601431732872502841691141142014

    2006/2007 N=1542008 N=1662009 N=1602010 N=1432011 N=1612012 N=2872013 N=2502014 N=2842015 N=1692016 N=1142017 N=114

    Imipenemn.g.n.g.n.g.n.g.n.g.0.250.250.250.250.250.25

    Colistin0.50.50.5121120.50.50.5

    Nalidixinsäure256256256256256256256256256256256

    Ciprofloxacinn.g.n.g.n.g.n.g.n.g.323232323232

    Enrofloxacin3232323232323232323232

    Cefotaxim116326464646464646464

    Ceftiofur264128128128128128128128128128

    Kalb

    2006/2007 N=154

    2008 N=166

    2009 N=160

    2010 N=143

    2011 N=161

    2012 N=287

    2013 N=250

    resistente Stämme [%]Achsentitel

    ESBL

    2006/2007 N=154

    2008 N=166

    2009 N=160

    2010 N=143

    2011 N=161

    2012 N=287

    2013 N=250

    2014 N=284

    2015 N=169

    2016 N=114

    2017 N=114

    [%] resistente Stämme

    Tabelle2

    2006/2007 N=154

    2008 N=166

    2009 N=160

    2010 N=143

    2011 N=161

    2012 N=287

    2013 N=250

    2014 N=284

    2015 N=169

    2016 N=114

    2017 N=114

    log2 MHK90-Wert

    Ferkel

    ESBL Kalb

    JahrKalbSchweinGeflügel

    2006/200772.30.2

    20081141.4

    2009193.81.8

    2010183.91.4

    201125.410.63.6

    2012207.92.3

    201329.20.6

    2014340.6

    201526.75.51

    201629.83.73.6

    Ferkel

    2006/2007

    2008

    2009

    2010

    2011

    2012

    2013

    2014

    2015

    2016

    Prävalenz ESBL bildender E. coli [%]

    Pute

    Masthahn

    E. coliFerkel

    2006/2007 N=3452008 N=2402009 N=1242010 N=1562011 N=1832012 N=1502015 N=1342016 N=1332017 N=118

    Ampicillin62676971.475.47457.562.462.7

    Amox/Clav32211.32.21.3303.4

    Cephalothin27191928.623.719.421.119.5

    Chloramphenicol31262724.232.822.7

    Gentamicin106111310.911.32.26.87.7

    Tetrazyklin80737778.979.272.759.762.455.6

    Trimeth/Sulfa50506155.9595643.351.145.3

    Summe

    n=3452401241561831501341331181583

    2006/2007 N=3452008 N=2402009 N=1242010 N=1562011 N=1832012 N=1502015 N=1342016 N=1332017 N=118

    Imipenemn.g.n.g.n.g.n.g.n.g.0.250.250.250.25

    Colistin40.5488880.54

    Nalidixinsäure128256256128128256256128128

    Ciprofloxacinn.g.n.g.n.g.n.g.n.g.40.50.50.5

    Enrofloxacin0.5110.50.58211

    Cefotaxim0.120.120.120.120.120.50.120.120.12

    Ceftiofur0.50.50.50.50.5110.50.5

    Masthahn

    2006/2007 N=345

    2008 N=240

    2009 N=124

    2010 N=156

    2011 N=183

    2012 N=150

    2015 N=134

    2016 N=133

    2017 N=118

    [%] resistente Stämme

    Colistin

    2006/2007 N=345

    2008 N=240

    2009 N=124

    2010 N=156

    2011 N=183

    2012 N=150

    2015 N=134

    2016 N=133

    2017 N=118

    log2 MHK90-Wert

    E. coli PutePutealle Indikationen

    2006/2007 N=1662006/2007 N=1662008 N=1332009 N=852010 N=952011 N=1252012 N=1592013 N=1092014 N=1102015 N=1142016 N=962017 N=64

    Ampicillin61.961.965.473.542.159.749.7334033.343.845.3

    Amoxi/Clav2.42.41.55.31.151.30.91.82.63.10

    Chloramph14.914.921.126.621.125.818.922

    Enrofloxacin334.504.21.51.35.56.46.15.26.3

    Gentamicin1.81.82.32.311.613.68.803.72.66.39.4

    Tetrazyklin70.270.262.452.836.84827.716.537.315.82523.4

    Trimet/Sulfa35.735.721.821.521.122.425.88.330713.510.9

    n=166166133859512515910911011496641422

    2006/2007 N=1662008 N=1332009 N=852010 N=952011 N=1252012 N=1592013 N=1092014 N=1102015 N=1142016 N=962017 N=64

    Imipenemn.g.n.g.n.g.n.g.0.250.250.250.250.250.250.25

    Colistin0.50.580.588120.50.50.5

    Nalidixinsäure256128128256256256128256128256128

    Ciprofloxacinn.g.n.g.n.g.n.g.0.250.50.50.50.50.50.5

    Cefotaxim0.120.120.120.120.120.120.120.120.120.120.12

    Ceftiofur0.50.50.50.50.50.50.50.50.50.50.5

    2006/2007 N=166

    2006/2007 N=166

    2008 N=133

    2009 N=85

    2010 N=95

    2011 N=125

    2012 N=159

    2013 N=109

    2014 N=110

    2015 N=114

    2016 N=96

    2017 N=64

    [%] resistente Stämme

    2006/2007 N=166

    2008 N=133

    2009 N=85

    2010 N=95

    2011 N=125

    2012 N=159

    2013 N=109

    2014 N=110

    2015 N=114

    2016 N=96

    2017 N=64

    log2 MHK90-Wert

    E. coliMasthahn

    2006/2007 N=302008 N=212009 N=292010 N=422011 N=742012 N=352013 N=382014 N=312015 N=1092016 N=772017 N=45

    Ampicillin6343525035.642.935.838.73335.144.4

    Amoxi/Clav1710311.91.411.4001.86.52.2

    Cephalothin37242723.825.915.86.56.415.615.6

    Chloramph10537.16.88.617.6

    Enrofloxacin3539.59.65.75.39.76.42.62.2

    Gentamicin3004.89.614.37.93.23.77.82.2

    Tetrazyklin40242133.335.634.323.735.516.518.226.7

    Trimet/Sulfa4314301916.414.318.425.823.916.920

    n=30212942743538311097745531

    2006/2007 N=302008 N=212009 N=292010 N=422011 N=742012 N=352013 N=382014 N=312015 N=1092016 N=772017 N=45

    Ceftiofur10.50.540.5160.50.50.50.50.5

    Cefotaxim0.50.120.1240.12160.120.120.120.250.12

    Nalidixinsäure256256256256256256256256256128256

    Ciprofloxacinn.g.n.g.n.g.n.g.n.g.0.50.540.50.50.5

    Colistin0.50.50.5111110.50.50.5

    0.0150.030.060.120.250.51248163264

    log2

    -6-5-4-3-2-10123456

    2006/2007 N=302008 N=212009 N=292010 N=422011 N=742012 N=352013 N=382014 N=312015 N=109

    Ceftiofur0-1-12-14-1-1-1

    Cefotaxim-1-3-32-34-3-3-3

    Nalidixinsäure888888888

    Ciprofloxacinn.g.n.g.n.g.n.g.n.g.-1-12-1

    Colistin-1-1-100000-1

    2006/2007 N=30

    2008 N=21

    2009 N=29

    2010 N=42

    2011 N=74

    2012 N=35

    2013 N=38

    2014 N=31

    2015 N=109

    2016 N=77

    2017 N=45

    [%] resistente Stämme

    2006/2007 N=30

    2008 N=21

    2009 N=29

    2010 N=42

    2011 N=74

    2012 N=35

    2013 N=38

    2014 N=31

    2015 N=109

    2016 N=77

    2017 N=45

    log2 MHK90-Wert

    Tab. 1.6. Anteil mcr-1 positiver Isolate an Colistin-resistenten (E. coli)

    SchweinRindGeflügelOthers

    2004/050%0%0%0%

    2005/060%0%0%0%

    2006/076%25%33%0%

    20085%0%64%0%

    200927%0%92%0%

    201047%45%77%0%

    201149%0%85%0%

    201244%0%95%100%

    2013*62%25%0%

    2014*45%57%0%

    201554%0%50%0%

    Table 1.4. Anteil Colistin-resistenter Isolate am Probeneingang

    SchweinRindGeflügelOthers

    2004/055.1%0.7%0.5%0.0%

    2005/063.5%1.1%0.4%0.0%

    2006/079.7%2.2%2.7%3.6%

    20085.7%4.5%3.3%4.5%

    20099.4%3.4%5.5%0.0%

    201012.4%2.2%4.5%0.8%

    201117.8%1.5%5.3%1.7%

    201215.8%0.7%5.2%0.0%

    2013*4.9%1.1%0.0%

    2014*2.1%2.1%1.1%

    201512.3%3.4%0.5%1.0%

    Table 1.5. Anteil mcr-1 positiver Isolate am Probeneingang (E. coli)

    SchweinRindGeflügelOthers

    2004/050.0%0.0%0.0%0.0%

    2005/060.0%0.0%0.0%0.0%

    2006/070.6%0.5%0.9%0.0%

    20080.3%0.0%2.1%0.0%

    20092.6%0.0%5.1%0.0%

    20105.8%1.0%3.4%0.0%

    20118.7%0.0%4.5%0.0%

    20126.9%0.0%5.0%1.7%

    2013*3.0%0.3%0.0%

    2014*0.9%1.2%0.0%

    20156.6%0.0%0.3%0.0%

    Schwein

    Rind

    Geflügel

    Schwein

    Rind

    Geflügel

    Schwein

    Rind

    Geflügel

  • Seite 29 Symposium Antibiotikaresistenz in der LM-Kette, Heike Kaspar

    Ergebnisse

    E. coli, Pute, MHK90-Daten, verschiedene Indikationen; 2006 - 2017

    0,0625

    0,125

    0,25

    0,5

    1

    2

    4

    8

    16

    32

    64

    128

    256

    Imipenem Colistin Nalidixinsäure Ciprofloxacin Cefotaxim Ceftiofur

    log2

    MHK

    90-W

    ert

    2006/2007 N=166 2008 N=133 2009 N=85 2010 N=95

    2011 N=125 2012 N=159 2013 N=109 2014 N=110

    2015 N=114 2016 N=96 2017 N=64

    Ciprofloxacin ab 2012 untersucht

  • Seite 30

    E. coli, Broiler, verschiedene Indikationen; 2006 - 2017

    Ergebnisse

    Symposium Antibiotikaresistenz in der LM-Kette, Heike Kaspar

    Diagramm1

    AmpicillinAmpicillinAmpicillinAmpicillinAmpicillinAmpicillinAmpicillinAmpicillinAmpicillinAmpicillinAmpicillin

    Amoxi/ClavAmoxi/ClavAmoxi/ClavAmoxi/ClavAmoxi/ClavAmoxi/ClavAmoxi/ClavAmoxi/ClavAmoxi/ClavAmoxi/ClavAmoxi/Clav

    ChloramphChloramphChloramphChloramphChloramphChloramphChloramphChloramphChloramphChloramphChloramph

    EnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacinEnrofloxacin

    GentamicinGentamicinGentamicinGentamicinGentamicinGentamicinGentamicinGentamicinGentamicinGentamicinGentamicin

    TetrazyklinTetrazyklinTetrazyklinTetrazyklinTetrazyklinTetrazyklinTetrazyklinTetrazyklinTetrazyklinTetrazyklinTetrazyklin

    Trimet/SulfaTrimet/SulfaTrimet/SulfaTrimet/SulfaTrimet/SulfaTrimet/SulfaTrimet/SulfaTrimet/SulfaTrimet/SulfaTrimet/SulfaTrimet/Sulfa

    2006/2007 N=30

    2008 N=21

    2009 N=29

    2010 N=42

    2011 N=74

    2012 N=35

    2013 N=38

    2014 N=31

    2015 N=109

    2016 N=77

    2017 N=45

    [%] resistente Stämme

    63

    43

    52

    50

    35.6

    42.9

    35.8

    38.7

    33

    35.1

    44.4

    17

    10

    3

    11.9

    1.4

    11.4

    0

    0

    1.8

    6.5

    2.2

    10

    5

    3

    7.1

    6.8

    8.6

    17.6

    3

    5

    3

    9.5

    9.6

    5.7

    5.3

    9.7

    6.4

    2.6

    2.2

    3

    0

    0

    4.8

    9.6

    14.3

    7.9

    3.2

    3.7

    7.8

    2.2

    40

    24

    21

    33.3

    35.6

    34.3

    23.7

    35.5

    16.5

    18.2

    26.7

    43

    14

    30

    19

    16.4

    14.3

    18.4

    25.8

    23.9

    16.9

    20

    Kalb

    E. coli Kalb

    2006/2007 N=1542008 N=1662009 N=1602010 N=1432011 N=1612012 N=2872013 N=2502014 N=2842015 N=1692016 N=1142017 N=114

    Ampicillin687076.376.979.776.377.671.568.666.775.4

    Amox/Clav18161519.617.41518.821.52610.516.7

    Cephalothin443741.348.342.446.439.4424349.1

    Chloramph495150.659.455.548.1

    Gentamicin2321253539.928.640.437.722.519.324.6

    Tetrazyklin717168.169.275.770.474.463.759.86465.8

    Trimeth/Sulfa445148.152.449.457.855.647.242.639.544.7

    Summe

    n=1541661601431732872502841691141142014

    2006/2007 N=1542008 N=1662009 N=1602010 N=1432011 N=1612012 N=2872013 N=2502014 N=2842015 N=1692016 N=1142017 N=114

    Imipenemn.g.n.g.n.g.n.g.n.g.0.250.250.250.250.250.25

    Colistin0.50.50.5121120.50.50.5

    Nalidixinsäure256256256256256256256256256256256

    Ciprofloxacinn.g.n.g.n.g.n.g.n.g.323232323232

    Enrofloxacin3232323232323232323232

    Cefotaxim116326464646464646464

    Ceftiofur264128128128128128128128128128

    Kalb

    2006/2007 N=154

    2008 N=166

    2009 N=160

    2010 N=143

    2011 N=161

    2012 N=287

    2013 N=250

    resistente Stämme [%]Achsentitel

    ESBL

    2006/2007 N=154

    2008 N=166

    2009 N=160

    2010 N=143

    2011 N=161

    2012 N=287

    2013 N=250

    2014 N=284

    2015 N=169

    2016 N=114

    2017 N=114

    [%] resistente Stämme

    Tabelle2

    2006/2007 N=154

    2008 N=166

    2009 N=160

    2010 N=143

    2011 N=161

    2012 N=287

    2013 N=250

    2014 N=284

    2015 N=169

    2016 N=114

    2017 N=114

    log2 MHK90-Wert

    Ferkel

    ESBL Kalb

    JahrKalbSchweinGeflügel

    2006/200772.30.2

    20081141.4

    2009193.81.8

    2010183.91.4

    201125.410.63.6

    2012207.92.3

    201329.20.6

    2014340.6

    201526.75.51

    201629.83.73.6

    Ferkel

    2006/2007

    2008

    2009

    2010

    2011

    2012

    2013

    2014

    2015

    2016

    Prävalenz ESBL bildender E. coli [%]

    Pute

    Masthahn

    E. coliFerkel

    2006/2007 N=3452008 N=2402009 N=1242010 N=1562011 N=1832012 N=1502015 N=1342016 N=1332017 N=118

    Ampicillin62676971.475.47457.562.462.7

    Amox/Clav32211.32.21.3303.4

    Cephalothin27191928.623.719.421.119.5

    Chloramphenicol31262724.232.822.7

    Gentamicin106111310.911.32.26.87.7

    Tetrazyklin80737778.979.272.759.762.455.6

    Trimeth/Sulfa50506155.9595643.351.145.3

    Summe

    n=3452401241561831501341331181583

    2006/2007 N=3452008 N=2402009 N=1242010 N=1562011 N=1832012 N=1502015 N=1342016 N=1332017 N=118

    Imipenemn.g.n.g.n.g.n.g.n.g.0.250.250.250.25

    Colistin40.5488880.54

    Nalidixinsäure128256256128128256256128128

    Ciprofloxacinn.g.n.g.n.g.n.g.n.g.40.50.50.5

    Enrofloxacin0.5110.50.58211

    Cefotaxim0.120.120.120.120.120.50.120.120.12

    Ceftiofur0.50.50.50.50.5110.50.5

    Masthahn

    2006/2007 N=345

    2008 N=240

    2009 N=124

    2010 N=156

    2011 N=183

    2012 N=150

    2015 N=134

    2016 N=133

    2017 N=118

    [%] resistente Stämme

    Colistin

    2006/2007 N=345

    2008 N=240

    2009 N=124

    2010 N=156

    2011 N=183

    2012 N=150

    2015 N=134

    2016 N=133

    2017 N=118

    log2 MHK90-Wert

    E. coli PutePutealle Indikationen

    2006/2007 N=1662006/2007 N=1662008 N=1332009 N=852010 N=952011 N=1252012 N=1592013 N=1092014 N=1102015 N=1142016 N=962017 N=64

    Ampicillin61.961.965.473.542.159.749.7334033.343.845.3

    Amoxi/Clav2.42.41.55.31.151.30.91.82.63.10

    Cephalothin42.842.836.833.422.1208.314.513.215.626.6

    Chloramph14.914.921.126.621.125.818.922

    Enrofloxacin334.504.21.51.35.56.46.15.26.3

    Gentamicin1.81.82.32.311.613.68.803.72.66.39.4

    Tetrazyklin70.270.262.452.836.84827.716.537.315.82523.4

    Trimet/Sulfa35.735.721.821.521.122.425.88.330713.510.9

    n=166166133859512515910911011496641422

    2006/2007 N=1662008 N=1332009 N=852010 N=952011 N=1252012 N=1592013 N=1092014 N=1102015 N=1142016 N=962017 N=64

    Imipenemn.g.n.g.n.g.n.g.0.250.250.250.250.250.250.25

    Colistin0.50.580.588120.50.50.5

    Nalidixinsäure256128128256256256128256128256128

    Ciprofloxacinn.g.n.g.n.g.n.g.0.250.50.50.50.50.50.5

    Cefotaxim0.120.120.120.120.120.120.120.120.120.120.12

    Ceftiofur0.50.50.50.50.50.50.50.50.50.50.5

    2006/2007 N=166

    2006/2007 N=166

    2008 N=133

    2009 N=85

    2010 N=95

    2011 N=125

    2012 N=159

    2013 N=109

    2014 N=110

    2015 N=114

    2016 N=96

    2017 N=64

    [%] resistente Stämme

    2006/2007 N=166

    2008 N=133

    2009 N=85

    2010 N=95

    2011 N=125

    2012 N=159

    2013 N=109

    2014 N=110

    2015 N=114

    2016 N=96

    2017 N=64

    log2 MHK90-Wert

    E. coliMasthahn

    2006/2007 N=302008 N=212009 N=292010 N=422011 N=742012 N=352013 N=382014 N=312015 N=1092016 N=772017 N=45

    Ampicillin6343525035.642.935.838.73335.144.4

    Amoxi/Clav1710311.91.411.4001.86.52.2

    Chloramph10537.16.88.617.6

    Enrofloxacin3539.59.65.75.39.76.42.62.2

    Gentamicin3004.89.614.37.93.23.77.82.2

    Tetrazyklin40242133.335.634.323.735.516.518.226.7

    Trimet/Sulfa4314301916.414.318.425.823.916.920

    n=30212942743538311097745531

    2006/2007 N=302008 N=212009 N=292010 N=422011 N=742012 N=352013 N=382014 N=312015 N=1092016 N=772017 N=45

    Ceftiofur10.50.540.5160.50.50.50.50.5

    Cefotaxim0.50.120.1240.12160.120.120.120.250.12

    Nalidixinsäure256256256256256256256256256128256

    Ciprofloxacinn.g.n.g.n.g.n.g.n.g.0.50.540.50.50.5

    Colistin0.50.50.5111110.50.50.5

    0.0150.030.060.120.250.51248163264

    log2

    -6-5-4-3-2-10123456

    2006/2007 N=302008 N=212009 N=292010 N=422011 N=742012 N=352013 N=382014 N=312015 N=109

    Ceftiofur0-1-12-14-1-1-1

    Cefotaxim-1-3-32-34-3-3-3

    Nalidixinsäure888888888

    Ciprofloxacinn.g.n.g.n.g.n.g.n.g.-1-12-1

    Colistin-1-1-100000-1

    2006/2007 N=30

    2008 N=21

    2009 N=29

    2010 N=42

    2011 N=74

    2012 N=35

    2013 N=38

    2014 N=31

    2015 N=109

    2016 N=77

    2017 N=45

    [%] resistente Stämme

    2006/2007 N=30

    2008 N=21

    2009 N=29

    2010 N=42

    2011 N=74

    2012 N=35

    2013 N=38

    2014 N=31

    2015 N=109

    2016 N=77

    2017 N=45

    log2 MHK90-Wert

    Tab. 1.6. Anteil mcr-1 positiver Isolate an Colistin-resistenten (E. coli)

    SchweinRindGeflügelOthers

    2004/050%0%0%0%

    2005/060%0%0%0%

    2006/076%25%33%0%

    20085%0%64%0%

    200927%0%92%0%

    201047%45%77%0%

    201149%0%85%0%

    201244%0%95%100%

    2013*62%25%0%

    2014*45%57%0%

    201554%0%50%0%

    Table 1.4. Anteil Colistin-resistenter Isolate am Probeneingang

    SchweinRindGeflügelOthers

    2004/055.1%0.7%0.5%0.0%

    2005/063.5%1.1%0.4%0.0%

    2006/079.7%2.2%2.7%3.6%

    20085.7%4.5%3.3%4.5%

    20099.4%3.4%5.5%0.0%

    201012.4%2.2%4.5%0.8%

    201117.8%1.5%5.3%1.7%

    201215.8%0.7%5.2%0.0%

    2013*4.9%1.1%0.0%

    2014*2.1%2.1%1.1%

    201512.3%3.4%0.5%1.0%

    Table 1.5. Anteil mcr-1 positiver Isolate am Probeneingang (E. coli)

    SchweinRindGeflügelOthers

    2004/050.0%0.0%0.0%0.0%

    2005/060.0%0.0%0.0%0.0%

    2006/070.6%0.5%0.9%0.0%

    20080.3%0.0%2.1%0.0%

    20092.6%0.0%5.1%0.0%

    20105.8%1.0%3.4%0.0%

    20118.7%0.0%4.5%0.0%

    20126.9%0.0%5.0%1.7%

    2013*3.0%0.3%0.0%

    2014*0.9%1.2%0.0%

    20156.6%0.0%0.3%0.0%

    Schwein

    Rind

    Geflügel

    Schwein

    Rind

    Geflügel

    Schwein

    Rind

    Geflügel

  • Seite 31

    E. coli, Broiler, MHK90-Daten, verschiedene Indikationen; 2006 - 2017

    Ergebnisse

    Symposium Antibiotikaresistenz in der LM-Kette, Heike Kaspar

    Diagramm1

    CeftiofurCeftiofurCeftiofurCeftiofurCeftiofurCeftiofurCeftiofurCeftiofurCeftiofurCeftiofurCeftiofur

    CefotaximCefotaximCefotaximCefotaximCefotaximCefotaximCefotaximCefotaximCefotaximCefotaximCefotaxim

    NalidixinsäureNalidixinsäureNalidixinsäureNalidixinsäureNalidixinsäureNalidixinsäureNalidixinsäureNalidixinsäureNalidixinsäureNalidixinsäureNalidixinsäure

    CiprofloxacinCiprofloxacinCiprofloxacinCiprofloxacinCiprofloxacinCiprofloxacinCiprofloxacinCiprofloxacinCiprofloxacinCiprofloxacinCiprofloxacin

    ColistinColistinColistinColistinColistinColistinColistinColistinColistinColistinColistin

    2006/2007 N=30

    2008 N=21

    2009 N=29

    2010 N=42

    2011 N=74

    2012 N=35

    2013 N=38

    2014 N=31

    2015 N=109

    2016 N=77

    2017 N=45

    log2 MHK90-Wert

    1

    0.5

    0.5

    4

    0.5

    16

    0.5

    0.5

    0.5

    0.5

    0.5

    0.5

    0.12

    0.12

    4

    0.12

    16

    0.12

    0.12

    0.12

    0.25

    0.12

    256

    256

    256

    256

    256

    256

    256

    256

    256

    128

    256

    0

    0

    0

    0

    0

    0.5

    0.5

    4

    0.5

    0.5

    0.5

    0.5

    0.5

    0.5

    1

    1

    1

    1

    1

    0.5

    0.5

    0.5

    Kalb

    E. coli Kalb

    2006/2007 N=1542008 N=1662009 N=1602010 N=1432011 N=1612012 N=2872013 N=2502014 N=2842015 N=1692016 N=1142017 N=114

    Ampicillin687076.376.979.776.377.671.568.666.775.4

    Amox/Clav18161519.617.41518.821.52610.516.7

    Cephalothin443741.348.342.446.439.4424349.1

    Chloramph495150.659.455.548.1

    Gentamicin2321253539.928.640.437.722.519.324.6

    Tetrazyklin717168.169.275.770.474.463.759.86465.8

    Trimeth/Sulfa445148.152.449.457.855.647.242.639.544.7

    Summe

    n=1541661601431732872502841691141142014

    2006/2007 N=1542008 N=1662009 N=1602010 N=1432011 N=1612012 N=2872013 N=2502014 N=2842015 N=1692016 N=1142017 N=114

    Imipenemn.g.n.g.n.g.n.g.n.g.0.250.250.250.250.250.25

    Colistin0.50.50.5121120.50.50.5

    Nalidixinsäure256256256256256256256256256256256

    Ciprofloxacinn.g.n.g.n.g.n.g.n.g.323232323232

    Enrofloxacin3232323232323232323232

    Cefotaxim116326464646464646464

    Ceftiofur264128128128128128128128128128

    Kalb

    2006/2007 N=154

    2008 N=166

    2009 N=160

    2010 N=143

    2011 N=161

    2012 N=287

    2013 N=250

    resistente Stämme [%]Achsentitel

    ESBL

    2006/2007 N=154

    2008 N=166

    2009 N=160

    2010 N=143

    2011 N=161

    2012 N=287

    2013 N=250

    2014 N=284

    2015 N=169

    2016 N=114

    2017 N=114

    [%] resistente Stämme

    Tabelle2

    2006/2007 N=154

    2008 N=166

    2009 N=160

    2010 N=143

    2011 N=161

    2012 N=287

    2013 N=250

    2014 N=284

    2015 N=169

    2016 N=114

    2017 N=114

    log2 MHK90-Wert

    Ferkel

    ESBL Kalb

    JahrKalbSchweinGeflügel

    2006/200772.30.2

    20081141.4

    2009193.81.8

    2010183.91.4

    201125.410.63.6

    2012207.92.3

    201329.20.6

    2014340.6

    201526.75.51

    201629.83.73.6

    Ferkel

    2006/2007

    2008

    2009

    2010

    2011

    2012

    2013

    2014

    2015

    2016

    Prävalenz ESBL bildender E. coli [%]

    Pute

    Masthahn

    E. coliFerkel

    2006/2007 N=3452008 N=2402009 N=1242010 N=1562011 N=1832012 N=1502015 N=1342016 N=1332017 N=118

    Ampicillin62676971.475.47457.562.462.7

    Amox/Clav32211.32.21.3303.4

    Cephalothin27191928.623.719.421.119.5

    Chloramphenicol31262724.232.822.7

    Gentamicin106111310.911.32.26.87.7

    Tetrazyklin80737778.979.272.759.762.455.6

    Trimeth/Sulfa50506155.9595643.351.145.3

    Summe

    n=3452401241561831501341331181583

    2006/2007 N=3452008 N=2402009 N=1242010 N=1562011 N=1832012 N=1502015 N=1342016 N=1332017 N=118

    Imipenemn.g.n.g.n.g.n.g.n.g.0.250.250.250.25

    Colistin40.5488880.54

    Nalidixinsäure128256256128128256256128128

    Ciprofloxacinn.g.n.g.n.g.n.g.n.g.40.50.50.5

    Enrofloxacin0.5110.50.58211

    Cefotaxim0.120.120.120.120.120.50.120.120.12

    Ceftiofur0.50.50.50.50.5110.50.5

    Masthahn

    2006/2007 N=345

    2008 N=240

    2009 N=124

    2010 N=156

    2011 N=183

    2012 N=150

    2015 N=134

    2016 N=133

    2017 N=118

    [%] resistente Stämme

    Colistin

    2006/2007 N=345

    2008 N=240

    2009 N=124